Aktualisierte S3-Leitlinie Colitis ulcerosa

Autoren Torsten Kucharzik1*, Axel U. Dignass2*, Raja Atreya3, Bernd Bokemeyer4, Philip Esters2, Klaus Herrlinger5, Klaus Kannengießer1, Peter Kienle6, Jost Langhorst7, Andreas Lügering8, Stefan Schreiber9, Andreas Stallmach10, Jürgen Stein11, Andreas Sturm12, Niels Teich13, Britta Siegmund14 Collaborators: Tilo Andus, Frank Autschbach, Oliver Bachmann, Gustavo Baretton, Daniel C. Baumgart, Dominik Bettenworth, Michael Bläker, Stephan Buderus, Jürgen Büning, Robert Ehehalt, Klaus Fellermann, Stefan Fichtner-Feigl, Martin Götz, Cordula Gross, Franz Hartmann, Petra Hartmann, Susanne In der Smitten, Winfried Häuser, Ulf Helwig, Birgit Kaltz, Inken Kanbach, Klaus-Michael Keller, Jochen Klaus, Sibylle Koletzko, Anton J. Kroesen, Wolfgang Kruis, Tanja Kühbacher, Ludger Leifeld, Christian Maaser, Harald Matthes, Gero Moog, Johann Ockenga, Andrea Pace, Max Reinshagen, Emile Rijcken, Eduard F. Stange, Claudia Veltkamp, Jennifer Zemke

[1]  B. Sands,et al.  Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  Siddharth Singh,et al.  Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. , 2019, The Cochrane database of systematic reviews.

[3]  J. Dahlerup,et al.  Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection. , 2019, Gastroenterology.

[4]  T. Louie,et al.  Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials. , 2019, The Lancet. Infectious diseases.

[5]  S. Wong,et al.  Systematic review with meta‐analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation , 2019, Alimentary pharmacology & therapeutics.

[6]  S. Vermeire,et al.  Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  A. Stallmach,et al.  Aktuelle Konzepte zur Diagnostik und Therapie der Clostridioides [Clostridium]-difficile-Infektion bei Patienten mit chronisch-entzündlichen Darmerkrankungen , 2018, Zeitschrift für Gastroenterologie.

[8]  W. Reinisch,et al.  Pharmacokinetics and safety of fidaxomicin in patients with inflammatory bowel disease and Clostridium difficile infection: an open-label Phase IIIb/IV study (PROFILE) , 2018, The Journal of antimicrobial chemotherapy.

[9]  M. Wilcox,et al.  Bezlotoxumab for Clostridium difficile Infection Complicating Inflammatory Bowel Disease. , 2018, Gastroenterology.

[10]  G. Sivaramakrishnan,et al.  Which Antimicrobial Agent is Likely to be the Best for Treating Clostridium difficile Infections? A Bayesian Network Meta-Analysis of Randomized Clinical Trials , 2018, Drug Research.

[11]  M. Wilcox,et al.  Comparative efficacy of treatments for Clostridium difficile infection: a systematic review and network meta-analysis. , 2018, The Lancet. Infectious diseases.

[12]  D. Pardi,et al.  Low Cure Rates in Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  R. Long,et al.  Safety and Side Effects of Rifampin versus Isoniazid in Children , 2018, The New England journal of medicine.

[14]  R. Long,et al.  Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults , 2018, The New England journal of medicine.

[15]  M. Young,et al.  Fidaxomicin vs Vancomycin for the Treatment of a First Episode of Clostridium Difficile Infection: A Meta-analysis and Systematic Review , 2018, Cureus.

[16]  K. Farkas,et al.  New Promising Combo Therapy in Inflammatory Bowel Diseases Refractory to Anti-TNF Agents: Cyclosporine Plus Vedolizumab. , 2018, Journal of Crohn's & colitis.

[17]  L. Peyrin-Biroulet,et al.  Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study , 2018, Alimentary pharmacology & therapeutics.

[18]  J. Rosenberg,et al.  Pouch failures following ileal pouch–anal anastomosis for ulcerative colitis , 2018, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[19]  A. Amiot,et al.  Long-term Follow-up After Ileorectal Anastomosis for Ulcerative Colitis: A GETAID/GETAID Chirurgie Multicenter Retrospective Cohort of 343 Patients , 2017, Annals of surgery.

[20]  O. Faiz,et al.  The Impact of Preoperative Serum Anti-TNFα Therapy Levels on Early Postoperative Outcomes in Inflammatory Bowel Disease Surgery. , 2017, Annals of surgery.

[21]  M. Barone,et al.  Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn’s Disease: A Systematic Review of Randomized Trials , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[22]  S. Vermeire,et al.  Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies , 2017, Journal of Crohn's & colitis.

[23]  M. Allez,et al.  Successful Treatment With Ustekinumab for Chronic Refractory Pouchitis. , 2017, Journal of Crohn's & colitis.

[24]  P. Siersema,et al.  Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease , 2017, Inflammatory bowel diseases.

[25]  S. Vermeire,et al.  Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus—A Multicenter Retrospective Study , 2017, Inflammatory bowel diseases.

[26]  C. Hollenbeak,et al.  Association of Preoperative Anti–Tumor Necrosis Factor Therapy With Adverse Postoperative Outcomes in Patients Undergoing Abdominal Surgery for Ulcerative Colitis , 2017, JAMA surgery.

[27]  A. Amiot,et al.  Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative Colitis , 2017, Journal of Crohn's & colitis.

[28]  J. Andrews,et al.  Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[29]  A. Taher,et al.  Insights into the diagnosis and management of iron deficiency in inflammatory bowel disease , 2017, Expert review of hematology.

[30]  V. Tahan,et al.  Successful treatment of chronic refractory pouchitis with vedolizumab , 2017, International Journal of Colorectal Disease.

[31]  P. Rutgeerts,et al.  Chromoendoscopy versus narrow band imaging in UC: a prospective randomised controlled trial , 2017, Gut.

[32]  N. Kassebaum,et al.  Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management , 2017, American journal of hematology.

[33]  A. Amiot,et al.  One‐year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study , 2017, Alimentary pharmacology & therapeutics.

[34]  A. Evans,et al.  Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis. , 2017, Gastroenterology.

[35]  S. Laurberg,et al.  Paradoxical Impact of Ileal Pouch-Anal Anastomosis on Male and Female Fertility in Patients With Ulcerative Colitis , 2017, Diseases of the colon and rectum.

[36]  A. Zinsmeister,et al.  Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[37]  Inge Christoffer Olsen,et al.  Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial , 2017, The Lancet.

[38]  C. Langner,et al.  Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. , 2017, Journal of Crohn's & colitis.

[39]  B. Siegmund.  Cytomegalovirus infection associated with inflammatory bowel disease. , 2017, The lancet. Gastroenterology & hepatology.

[40]  P. Messiaen,et al.  The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus‐negative immunocompromised patients: A systematic review , 2017, Transplant infectious disease : an official journal of the Transplantation Society.

[41]  J. Stein,et al.  A prospective cohort study to assess the relevance of Vedolizumab drug level monitoring in IBD patients , 2017, Zeitschrift für Gastroenterologie.

[42]  C. Evans,et al.  Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults. , 2017, The Cochrane database of systematic reviews.

[43]  J. Langhorst,et al.  Randomised clinical trial: yoga vs written self‐care advice for ulcerative colitis , 2017, Alimentary pharmacology & therapeutics.

[44]  O. Faiz,et al.  Systematic review with meta‐analysis: the management of chronic refractory pouchitis with an evidence‐based treatment algorithm , 2017, Alimentary pharmacology & therapeutics.

[45]  Nayoung Kim,et al.  Risk Factors for Vitamin D, Zinc, and Selenium Deficiencies in Korean Patients with Inflammatory Bowel Disease , 2017, Gut and liver.

[46]  S. Vermeire,et al.  Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[47]  J. Reimund,et al.  Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy? , 2017, Gut.

[48]  M. Goetz,et al.  Successful treatment of pouchitis with Vedolizumab, but not fecal microbiota transfer (FMT), after proctocolectomy in ulcerative colitis , 2017, International Journal of Colorectal Disease.

[49]  M. Pai,et al.  Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  J. Stein,et al.  Current evaluation and management of anemia in patients with inflammatory bowel disease , 2017, Expert review of gastroenterology & hepatology.

[51]  X. Roblin,et al.  Golimumab pharmacokinetics in ulcerative colitis: a literature review , 2017, Therapeutic advances in gastroenterology.

[52]  R. Eliakim,et al.  Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab , 2017, Alimentary pharmacology & therapeutics.

[53]  D. Conte,et al.  The role of dietary supplements in inflammatory bowel disease: a systematic review , 2016, European journal of gastroenterology & hepatology.

[54]  S. Kudo,et al.  Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer. , 2016, Gastroenterology.

[55]  J. Hampe,et al.  Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease – a prospective multicenter observational study , 2016, Alimentary pharmacology & therapeutics.

[56]  D. V. van Langenberg,et al.  Toward an Algorithm for the Diagnosis and Management of CMV in Patients with Colitis , 2016, Inflammatory bowel diseases.

[57]  J. Langhorst,et al.  Myrrhe, Kamille und Kaffeekohle in der Therapie von Patienten mit Colitis ulcerosa , 2016, Zeitschrift für Phytotherapie.

[58]  T. Matsui,et al.  Adalimumab Monotherapy and a Combination with Azathioprine for Crohn's Disease: A Prospective, Randomized Trial. , 2016, Journal of Crohn's & colitis.

[59]  J. Rahier,et al.  Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient: A Clinical Quandary , 2016, Inflammatory bowel diseases.

[60]  M. Mellow,et al.  Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease , 2016, Inflammatory bowel diseases.

[61]  A. Khoruts,et al.  Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[62]  N. Teich,et al.  First Occurrence of Severe Extraintestinal Manifestations of Crohn's Disease Following Faecal Microbiota Transplantation. , 2016, Journal of Crohn's & colitis.

[63]  A. Kaser,et al.  Long-term Efficacy of Vedolizumab for Ulcerative Colitis , 2016, Journal of Crohn's & colitis.

[64]  D. Ong,et al.  Anemia and iron deficiency in gastrointestinal and liver conditions , 2016, World journal of gastroenterology.

[65]  M. Cuatrecasas,et al.  Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD , 2016, Gut.

[66]  B. Sands,et al.  Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[67]  J. Mansfield,et al.  Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial , 2016, The lancet. Gastroenterology & hepatology.

[68]  P. Higgins,et al.  Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease: A Meta-analysis , 2016, Inflammatory bowel diseases.

[69]  O. Dekkers,et al.  European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[70]  D. Rubin,et al.  Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies , 2016, Inflammatory bowel diseases.

[71]  Steven J Brown,et al.  Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection. , 2016, Gastroenterology.

[72]  A. Gasbarrini,et al.  Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update. , 2016, World journal of gastroenterology.

[73]  J. Gisbert,et al.  Maintenance therapy options for ulcerative colitis , 2016, Expert opinion on pharmacotherapy.

[74]  F. Rorsman,et al.  Active cytomegalovirus infection diagnosed by real-time PCR in patients with inflammatory bowel disease: a prospective, controlled observational study* , 2016, Scandinavian journal of gastroenterology.

[75]  S. Schreiber,et al.  Vedolizumab induction therapy for inflammatory bowel disease in clinical practice – a nationwide consecutive German cohort study , 2016, Alimentary pharmacology & therapeutics.

[76]  A. Moss,et al.  Systematic Review and Meta-Analysis: Serum Infliximab Levels During Maintenance Therapy and Outcomes in Inflammatory Bowel Disease. , 2016, Journal of Crohn's & colitis.

[77]  G. Kaplan,et al.  Targeted Biopsies Identify Larger Proportions of Patients With Colonic Neoplasia Undergoing High-Definition Colonoscopy, Dye Chromoendoscopy, or Electronic Virtual Chromoendoscopy. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[78]  K. Whelan,et al.  Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease , 2016, Inflammatory bowel diseases.

[79]  J. Srinivasan,et al.  Successful treatment of chronic Pouchitis utilizing fecal microbiota transplantation (FMT): a case report , 2016, International Journal of Colorectal Disease.

[80]  B. Feagan,et al.  Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. , 2016, The Cochrane database of systematic reviews.

[81]  E. Schwartz.  Perioperative Parenteral Nutrition in Adults With Inflammatory Bowel Disease: A Review of the Literature. , 2016, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[82]  M. Kwak,et al.  Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis , 2016, Inflammatory bowel diseases.

[83]  J. Gisbert,et al.  The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis , 2016, The American Journal of Gastroenterology.

[84]  W. Kruis,et al.  Iron Deficiency, Zinc, Magnesium, Vitamin Deficiencies in Crohn's Disease: Substitute or Not? , 2016, Digestive Diseases.

[85]  I. Endo,et al.  Prolonged Medical Therapy Increases the Risk of Surgical Complications in Patients with Severe Ulcerative Colitis , 2016, Digestive Surgery.

[86]  A. Akobeng,et al.  Glutamine for induction of remission in Crohn's disease. , 2016, The Cochrane database of systematic reviews.

[87]  M. Tremelling,et al.  Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease. , 2016, Journal of Crohn's & colitis.

[88]  O. Dewit,et al.  Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis. , 2016, Gastroenterology.

[89]  G. Rogler,et al.  Alicaforsen, an antisense inhibitor of ICAM-1, as treatment for chronic refractory pouchitis after proctocolectomy: A case series , 2016, United European gastroenterology journal.

[90]  A. López-Guillermo,et al.  Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies. , 2016, Seminars in arthritis and rheumatism.

[91]  C. Ponsioen,et al.  Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[92]  J. Drenth,et al.  Cytomegalovirus in inflammatory bowel disease: A systematic review. , 2016, World journal of gastroenterology.

[93]  M. Silverberg,et al.  Infliximab to Treat Refractory Inflammation After Pelvic Pouch Surgery for Ulcerative Colitis. , 2016, Journal of Crohn's & colitis.

[94]  K. Deepak,et al.  Effect of Yoga-Based Intervention in Patients with Inflammatory Bowel Disease. , 2015, International journal of yoga therapy.

[95]  A. Di Leo,et al.  Escherichia coli Nissle 1917 in Ulcerative Colitis Treatment: Systematic Review and Meta-analysis. , 2015, Journal of gastrointestinal and liver diseases : JGLD.

[96]  P. Christos,et al.  The Effect of Breathing, Movement, and Meditation on Psychological and Physical Symptoms and Inflammatory Biomarkers in Inflammatory Bowel Disease: A Randomized Controlled Trial , 2015, Inflammatory bowel diseases.

[97]  J. Satsangi,et al.  Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease. , 2015, Gastroenterology.

[98]  R. Malekzadeh,et al.  A randomized, double blinded, placebo-controlled clinical trial of silymarin in ulcerative colitis , 2015, Chinese Journal of Integrative Medicine.

[99]  S. Tschudin-Sutter,et al.  Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[100]  J. Lefèvre,et al.  Restorative Proctocolectomy and Ileal Pouch-anal Anastomosis. , 2015, Annals of surgery.

[101]  P. Siersema,et al.  Comparison of Costs and Quality of Life in Ulcerative Colitis Patients with an Ileal Pouch-Anal Anastomosis, Ileostomy and Anti-TNFα Therapy. , 2015, Journal of Crohn's & colitis.

[102]  Siddharth Singh,et al.  Antiviral Therapy in Steroid-refractory Ulcerative Colitis with Cytomegalovirus: Systematic Review and Meta-analysis , 2015, Inflammatory bowel diseases.

[103]  L. Stitt,et al.  Development and validation of a histological index for UC , 2015, Gut.

[104]  S. Travis,et al.  Development and validation of the Nancy histological index for UC , 2015, Gut.

[105]  A. Amiot,et al.  Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic Strictures. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[106]  M. Plauth,et al.  White-Light or Narrow-Band Imaging Colonoscopy in Surveillance of Ulcerative Colitis: A Prospective Multicenter Study. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[107]  A. Hart,et al.  Low-Grade Dysplasia in Ulcerative Colitis: Risk Factors for Developing High-Grade Dysplasia or Colorectal Cancer , 2015, The American Journal of Gastroenterology.

[108]  C. Parker,et al.  The impact of biological interventions for ulcerative colitis on health-related quality of life. , 2015, The Cochrane database of systematic reviews.

[109]  C. Paterson,et al.  Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis: A Randomized, Placebo-controlled Clinical Trial , 2015, Journal of clinical gastroenterology.

[110]  H. Herfarth,et al.  Use of Biologics in Pouchitis: A Systematic Review , 2015, Journal of clinical gastroenterology.

[111]  A. Griffiths,et al.  Methotrexate for maintenance of remission in ulcerative colitis. , 2015, The Cochrane database of systematic reviews.

[112]  M. Mansourian,et al.  Efficacy of the Punica granatum peels aqueous extract for symptom management in ulcerative colitis patients. A randomized, placebo-controlled, clinical trial. , 2015, Complementary therapies in clinical practice.

[113]  C. Ponsioen,et al.  Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis. , 2015, Gastroenterology.

[114]  S. Ng,et al.  Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[115]  Ö. Kartal,et al.  Low Vitamin D Levels: Are Associated with Both Iron Deficiency and Anemia in Children and Adolescents? , 2015, Pediatric hematology and oncology.

[116]  J. Marshall,et al.  Systematic Review: Sequential Rescue Therapy in Severe Ulcerative Colitis Do the Benefits Outweigh the Risks? , 2015, Inflammatory bowel diseases.

[117]  S. Dalal,et al.  Systematic Review: Rectal Therapies for the Treatment of Distal Forms of Ulcerative Colitis , 2015, Inflammatory bowel diseases.

[118]  F. Argüelles-Arias,et al.  Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal , 2015, Inflammatory bowel diseases.

[119]  I. Kohane,et al.  Diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases , 2015, Alimentary pharmacology & therapeutics.

[120]  A. Ford,et al.  Systematic review and meta‐analysis: opportunistic infections and malignancies during treatment with anti‐integrin antibodies in inflammatory bowel disease , 2015, Alimentary pharmacology & therapeutics.

[121]  Yasuo Suzuki,et al.  Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis. , 2015, World journal of gastroenterology.

[122]  B. Warren,et al.  Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up , 2015, Gut.

[123]  I. Nagtegaal,et al.  Epstein-Barr virus in inflammatory bowel disease: the spectrum of intestinal lymphoproliferative disorders. , 2015, Journal of Crohn's & colitis.

[124]  R. Baldassano,et al.  Diet in the pathogenesis and treatment of inflammatory bowel diseases. , 2015, Gastroenterology.

[125]  J. Gisbert,et al.  Systematic review with meta‐analysis: the efficacy of a second anti‐TNF in patients with inflammatory bowel disease whose previous anti‐TNF treatment has failed , 2015, Alimentary pharmacology & therapeutics.

[126]  D. Clemmons,et al.  Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis. , 2015, Gastroenterology.

[127]  A. Hart,et al.  Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview , 2015, The American Journal of Gastroenterology.

[128]  J. Christle,et al.  The Impact of a Ten-Week Physical Exercise Program on Health-Related Quality of Life in Patients with Inflammatory Bowel Disease: A Prospective Randomized Controlled Trial , 2015, Digestion.

[129]  M. Bechtold,et al.  Effect of Immunosuppressive Therapies for the Treatment of Inflammatory Bowel Disease on Response to Routine Vaccinations: A Meta-Analysis , 2015, Digestive Diseases and Sciences.

[130]  Jacob E. Kurlander,et al.  A Meta-Analysis of the Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin, and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBS , 2015, The American Journal of Gastroenterology.

[131]  Alan Barkun,et al.  SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. , 2015, Gastrointestinal endoscopy.

[132]  R. Eliakim,et al.  Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[133]  F. Remzi,et al.  Laparoscopic IPAA Is Not Associated With Decreased Rates of Incisional Hernia and Small-Bowel Obstruction When Compared With Open Technique: Long-term Follow-up of a Case-Matched Study , 2015, Diseases of the colon and rectum.

[134]  J. Gisbert,et al.  European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. , 2015, Journal of Crohn's & colitis.

[135]  M. Nurmohamed,et al.  Key findings towards optimising adalimumab treatment: the concentration-effect curve. , 2015, Annals of the rheumatic diseases.

[136]  M. Petrovec,et al.  Diagnosing cytomegalovirus in patients with inflammatory bowel disease—by immunohistochemistry or polymerase chain reaction? , 2015, Virchows Archiv.

[137]  C. Kvasnovsky,et al.  Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease , 2015, Scandinavian journal of gastroenterology.

[138]  C. Redmond,et al.  An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[139]  J. Payer,et al.  Vitamin D therapy in inflammatory bowel diseases: who, in what form, and how much? , 2015, Journal of Crohn's & colitis.

[140]  C. Ponsioen,et al.  Short‐term morbidity and quality of life from a randomized clinical trial of close rectal dissection and total mesorectal excision in ileal pouch–anal anastomosis , 2015, The British journal of surgery.

[141]  R. Bagin,et al.  Induction of clinical and colonoscopic remission of mild–to–moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies , 2015, Alimentary pharmacology & therapeutics.

[142]  M. Büchler,et al.  Residual rectal mucosa after stapled vs. handsewn ileal J-pouch-anal anastomosis in patients with familial adenomatous polyposis coli (FAP)—a critical issue , 2015, Langenbeck's Archives of Surgery.

[143]  G. Pellino,et al.  Effect of Preoperative Biologic Drugs on Complications and Function After Restorative Proctocolectomy with Primary Ileal Pouch Formation: Systematic Review and Meta-analysis , 2015, Inflammatory bowel diseases.

[144]  M. O'Sullivan,et al.  Optimal vitamin D levels in Crohn's disease: a review , 2014, Proceedings of the Nutrition Society.

[145]  R. Veenendaal,et al.  Influence of Combination Therapy with Immune Modulators on Anti-TNF Trough Levels and Antibodies in Patients with IBD , 2014, Inflammatory bowel diseases.

[146]  S. Kedia,et al.  Management of acute severe ulcerative colitis. , 2014, World journal of gastrointestinal pathophysiology.

[147]  P. Fockens,et al.  Length of hospital stay and associated hospital costs with infliximab versus cyclosporine in severe ulcerative colitis , 2014, European journal of gastroenterology & hepatology.

[148]  C. J. van der Woude,et al.  Drug Therapies for Ulcerative Proctitis: Systematic Review and Meta-analysis , 2014, Inflammatory bowel diseases.

[149]  S. Hutfless,et al.  Family history of inflammatory bowel disease among patients with ulcerative colitis: a systematic review and meta-analysis. , 2014, Journal of Crohn's & colitis.

[150]  Mamoru Watanabe,et al.  A randomized clinical trial of mesalazine suppository: the usefulness and problems of central review of evaluations of colonic mucosal findings. , 2014, Journal of Crohn's & colitis.

[151]  E. Cabré,et al.  Intravenous corticosteroids in moderately active ulcerative colitis refractory to oral corticosteroids. , 2014, Journal of Crohn's & colitis.

[152]  K. Bendtzen,et al.  Antibodies Against Infliximab Are Associated with De Novo Development of Antibodies to Adalimumab and Therapeutic Failure in Infliximab-to-Adalimumab Switchers with IBD , 2014, Inflammatory bowel diseases.

[153]  A. Bitton,et al.  Oral Corticosteroids and the Risk of Serious Infections in Patients With Elderly-Onset Inflammatory Bowel Diseases , 2014, The American Journal of Gastroenterology.

[154]  R. Hodin,et al.  Does intramesorectal excision for ulcerative colitis impact bowel and sexual function when compared with total mesorectal excision? , 2014, American journal of surgery.

[155]  L. Leibovici,et al.  Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. , 2014, The Cochrane database of systematic reviews.

[156]  N. Senninger,et al.  Morbidity of Loop Ileostomy Closure after Restorative Proctocolectomy for Ulcerative Colitis and Familial Adenomatous Polyposis: a Systematic Review , 2014, Journal of Gastrointestinal Surgery.

[157]  K. Hood,et al.  Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels. , 2014, Journal of Crohn's & colitis.

[158]  U. Kopylov,et al.  Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease , 2014, Alimentary pharmacology & therapeutics.

[159]  M. Skup,et al.  Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3 , 2014, The American Journal of Gastroenterology.

[160]  S. Bickston,et al.  Vedolizumab for induction and maintenance of remission in ulcerative colitis. , 2014, The Cochrane database of systematic reviews.

[161]  M. Eberhardson,et al.  Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment. , 2014, Journal of Crohn's & colitis.

[162]  L. Guidi,et al.  Long-term Combination Therapy with Infliximab Plus Azathioprine Predicts Sustained Steroid-free Clinical Benefit in Steroid-dependent Ulcerative Colitis , 2014, Inflammatory bowel diseases.

[163]  B. Jiang,et al.  Meta-analysis: Fecal Calprotectin for Assessment of Inflammatory Bowel Disease Activity , 2014, Inflammatory bowel diseases.

[164]  C. Ha.  Risks of Infection among the Older Inflammatory Bowel Disease Patients , 2014, Current Treatment Options in Gastroenterology.

[165]  S. Kameoka,et al.  A treatment strategy for preventing pouchitis as a postoperative complication of ulcerative colitis: the significance of the management of cuffitis , 2014, Surgery Today.

[166]  G. Kaplan,et al.  Clostridium difficile infection worsens the prognosis of ulcerative colitis. , 2014, Canadian journal of gastroenterology & hepatology.

[167]  S. Targan,et al.  Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease , 2014, Antimicrobial Agents and Chemotherapy.

[168]  D. Vassilopoulos,et al.  Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases , 2014, Annals of the rheumatic diseases.

[169]  H. Tajiri,et al.  Adjunct antibiotic combination therapy for steroid‐refractory or ‐dependent ulcerative colitis: an open‐label multicentre study , 2014, Alimentary pharmacology & therapeutics.

[170]  A. Gasbarrini,et al.  Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy. , 2014, Journal of Crohn's & colitis.

[171]  E. Dekker,et al.  Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[172]  Mathias W Pletz,et al.  Fulminant Gastrointestinal Bleeding caused by EBV-triggered Hemophagocytic Lymphohistiocytosis: Report of a Case , 2014, Zeitschrift für Gastroenterologie.

[173]  W. Schwenk,et al.  [Clinical nutrition in surgery. Guidelines of the German Society for Nutritional Medicine]. , 2014, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[174]  W. Selby,et al.  Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[175]  E. Seidman,et al.  Antiviral therapy in cytomegalovirus-positive ulcerative colitis: a systematic review and meta-analysis. , 2014, World journal of gastroenterology.

[176]  A. Griffiths,et al.  Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. , 2014, Gastroenterology.

[177]  S. Kedia,et al.  Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study. , 2014, Journal of Crohn's & colitis.

[178]  A. Keshavarzian,et al.  A Randomized Controlled Trial of Mindfulness-Based Stress Reduction to Prevent Flare-Up in Patients with Inactive Ulcerative Colitis , 2014, Digestion.

[179]  P. Rutgeerts,et al.  Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis. , 2014, Gastroenterology.

[180]  P. Rutgeerts,et al.  Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial , 2014, Gut.

[181]  P. Bager,et al.  Helminth therapy (worms) for induction of remission in inflammatory bowel disease. , 2014, The Cochrane database of systematic reviews.

[182]  T. Fukui,et al.  Image-enhanced, chromo, and cap-assisted colonoscopy for improving adenoma/neoplasia detection rate: a systematic review and meta-analysis , 2014, Scandinavian journal of gastroenterology.

[183]  A. Moss,et al.  Antibodies to Infliximab and Risk of Infusion Reactions in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis , 2014, Inflammatory bowel diseases.

[184]  B. Schneider,et al.  Efficacy and safety of a herbal medicinal product containing myrrh, chamomile and coffee charcoal for the treatment of gastrointestinal disorders: a non-interventional study , 2014, BMJ open gastroenterology.

[185]  A. Ananthakrishnan,et al.  Review article: vitamin D and inflammatory bowel diseases , 2014, Alimentary pharmacology & therapeutics.

[186]  A. Amiot,et al.  European evidence based consensus for endoscopy in inflammatory bowel disease. , 2013, Journal of Crohn's & colitis.

[187]  E. Horváth-Puhó,et al.  Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort Study , 2013, The American Journal of Gastroenterology.

[188]  T. Fessler.  Trace elements in parenteral nutrition: a practical guide for dosage and monitoring for adult patients. , 2013, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[189]  D. Rubin,et al.  Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[190]  D. Conte,et al.  Nutritional deficiencies in inflammatory bowel disease: therapeutic approaches. , 2013, Clinical nutrition.

[191]  F. Virdis,et al.  Hemophagocytic lymphohistiocytosis caused by primary Epstein-Barr virus in patient with Crohn's disease. , 2013, World journal of gastrointestinal surgery.

[192]  G. Veres,et al.  ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents , 2013, Journal of pediatric gastroenterology and nutrition.

[193]  C. Buskens,et al.  Prolonged preoperative hospital stay is a risk factor for complications after emergency colectomy for severe colitis , 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[194]  W. Willett,et al.  A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. , 2013, Gastroenterology.

[195]  J. Rhodes,et al.  Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit , 2013, Alimentary pharmacology & therapeutics.

[196]  Luyi Wu,et al.  Acupuncture and Moxibustion for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2013, Evidence-based complementary and alternative medicine : eCAM.

[197]  U. Kopylov,et al.  The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab , 2013, Gut.

[198]  A. Michalsen,et al.  Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis – a double‐blind, double‐dummy study , 2013, Alimentary pharmacology & therapeutics.

[199]  A. Eriksson,et al.  Hyperbaric oxygen therapy does not improve the effects of standardized treatment in a severe attack of ulcerative colitis: a prospective randomized study , 2013, Scandinavian journal of gastroenterology.

[200]  P. Rutgeerts,et al.  Vedolizumab as induction and maintenance therapy for ulcerative colitis. , 2013, The New England journal of medicine.

[201]  L. Peyrin-Biroulet,et al.  5-Aminosalicylates and renal function monitoring in inflammatory bowel disease: a nationwide survey. , 2013, Journal of Crohn's & colitis.

[202]  T. Hibi,et al.  Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation – a placebo‐controlled study , 2013, Alimentary pharmacology & therapeutics.

[203]  G. Radford-Smith,et al.  Outcomes of salvage therapy for steroid‐refractory acute severe ulcerative colitis: ciclosporin vs. infliximab , 2013, Alimentary pharmacology & therapeutics.

[204]  S. Ng,et al.  A Review of Mortality and Surgery in Ulcerative Colitis: Milestones of the Seriousness of the Disease , 2013, Inflammatory bowel diseases.

[205]  B. Feagan,et al.  Are There Any Differences in the Efficacy and Safety of Different Formulations of Oral 5-ASA Used for Induction and Maintenance of Remission in Ulcerative Colitis? Evidence from Cochrane Reviews , 2013, Inflammatory bowel diseases.

[206]  R. Khanna,et al.  Low levels of vitamin D are common in patients with ileal pouches irrespective of pouch inflammation. , 2013, Journal of Crohn's & colitis.

[207]  J. Halfvarson,et al.  Infliximab as rescue therapy in hospitalised patients with steroid‐refractory acute ulcerative colitis: a long‐term follow‐up of 211 Swedish patients , 2013, Alimentary pharmacology & therapeutics.

[208]  L. Beyer-Berjot,et al.  A Total Laparoscopic Approach Reduces the Infertility Rate After Ileal Pouch-Anal Anastomosis: A 2-Center Study , 2013, Annals of surgery.

[209]  F. Remzi,et al.  Clinical value of surveillance pouchoscopy in asymptomatic ileal pouch patients with underlying inflammatory bowel disease , 2013, Surgical Endoscopy.

[210]  W. Willett,et al.  Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease , 2013, Gut.

[211]  W. Sandborn,et al.  52-Week Efficacy of Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis Who Failed Corticosteroids and/or Immunosuppressants , 2013, Inflammatory bowel diseases.

[212]  F. Carrat,et al.  Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. , 2013, Gastroenterology.

[213]  M. Cottone,et al.  Systematic review: macrophage activation syndrome in inflammatory bowel disease , 2013, Alimentary pharmacology & therapeutics.

[214]  Edgar Ramiterre,et al.  A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study , 2013, Annals of the rheumatic diseases.

[215]  Sergio Gutierrez-Ureña,et al.  A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study , 2013, Annals of the rheumatic diseases.

[216]  P. Deepak,et al.  Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: a 6-year analysis of the Nationwide Inpatient Sample , 2013, Clinical and experimental gastroenterology.

[217]  F. Remzi,et al.  Intraperitoneal or Subcutaneous: Does Location of the (Colo)rectal Stump Influence Outcomes After Laparoscopic Total Abdominal Colectomy for Ulcerative Colitis? , 2013, Diseases of the colon and rectum.

[218]  C. Buskens,et al.  Systematic review and meta‐analysis of laparoscopic versus open colectomy with end ileostomy for non‐toxic colitis , 2013, The British journal of surgery.

[219]  Douglas L. Nguyen,et al.  Mo2124 National Trends and Outcomes of Inflammatory Bowel Disease Patients Requiring in-Hospital Total Parenteral Nutrition Support , 2013 .

[220]  O. Dewit,et al.  Randomised clinical trial: once‐ vs. twice‐daily prolonged‐release mesalazine for active ulcerative colitis , 2013, Alimentary pharmacology & therapeutics.

[221]  Christopher F. Martin,et al.  Increased Risk of Pneumocystis Jiroveci Pneumonia Among Patients with Inflammatory Bowel Disease , 2013, Inflammatory bowel diseases.

[222]  J. Stein,et al.  Management of iron deficiency anemia in inflammatory bowel disease – a practical approach , 2013, Annals of gastroenterology.

[223]  A. Ananthakrishnan,et al.  Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. , 2013, Journal of Crohn's & colitis.

[224]  P. Collins.  Strategies for Detecting Colon Cancer and Dysplasia in Patients with Inflammatory Bowel Disease , 2013, Inflammatory bowel diseases.

[225]  J. Coffey,et al.  Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis , 2013, International Journal of Colorectal Disease.

[226]  S. Travis,et al.  Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study , 2013, Gut.

[227]  S. Travis,et al.  Association between the ulcerative colitis endoscopic index of severity (UCEIS) and outcomes in acute severe ulcerative colitis. , 2013, Journal of Crohn's & colitis.

[228]  Laurent Beaugerie,et al.  Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. , 2013, Journal of Crohn's & colitis.

[229]  E. Zoetendal,et al.  Duodenal infusion of donor feces for recurrent Clostridium difficile. , 2013, The New England journal of medicine.

[230]  H. Lehnert,et al.  Short‐term efficacy of tacrolimus in steroid‐refractory ulcerative colitis – experience in 130 patients , 2013, Alimentary pharmacology & therapeutics.

[231]  P. Austin,et al.  Impact of Clostridium difficile colitis on 5‐year health outcomes in patients with ulcerative colitis , 2012, Alimentary pharmacology & therapeutics.

[232]  M. Cuesta,et al.  Significantly Increased Pregnancy Rates After Laparoscopic Restorative Proctocolectomy: A Cross-Sectional Study , 2012, Annals of surgery.

[233]  S. Vermeire,et al.  Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. , 2012, Journal of Crohn's & colitis.

[234]  G. Guest,et al.  The Ideal Ileal-Pouch Design: A Long-Term Randomized Control Trial of J- vs W-Pouch Construction , 2012, Diseases of the colon and rectum.

[235]  J. Gisbert,et al.  Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial , 2012, The Lancet.

[236]  K. Bendtzen,et al.  Clinical implications of variations in anti‐infliximab antibody levels in patients with inflammatory bowel disease , 2012, Inflammatory bowel diseases.

[237]  R. Lopez,et al.  Adalimumab therapy in Crohn's disease of the ileal pouch , 2012, Inflammatory bowel diseases.

[238]  A. Cheifetz,et al.  Varicella zoster virus infection in inflammatory bowel disease , 2012, Inflammatory bowel diseases.

[239]  M. Thabane,et al.  Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. , 2012, The Cochrane database of systematic reviews.

[240]  R. Bagin,et al.  Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study. , 2012, Gastroenterology.

[241]  Zhiping Yang,et al.  Meta‐analysis: effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgery , 2012, Alimentary pharmacology & therapeutics.

[242]  M. V. van Oijen,et al.  High mucosal healing rates in 5‐ASA‐treated ulcerative colitis patients: Results of a meta‐analysis of clinical trials , 2012, Inflammatory bowel diseases.

[243]  S. Targan,et al.  Andrographis paniculata Extract (HMPL-004) for Active Ulcerative Colitis , 2012, The American Journal of Gastroenterology.

[244]  Ren Mao,et al.  Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta‐analysis of prospective studies , 2012, Inflammatory bowel diseases.

[245]  P. V. van Rheenen,et al.  Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy , 2012, Archives of Disease in Childhood.

[246]  B. Feagan,et al.  Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: A systematic review and meta‐analysis , 2012, Inflammatory bowel diseases.

[247]  W. Sandborn,et al.  Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry , 2012, The American Journal of Gastroenterology.

[248]  Mark A. Miller,et al.  Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[249]  M. Neurath,et al.  Mucosal healing in inflammatory bowel diseases: a systematic review , 2012, Gut.

[250]  N. Senninger,et al.  Timing of Restorative Proctocolectomy in Patients With Medically Refractory Ulcerative Colitis: The Patient’s Point of View , 2012, Diseases of the colon and rectum.

[251]  J. Gordillo,et al.  Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab: a case series , 2012, European journal of gastroenterology & hepatology.

[252]  L. Peyrin-Biroulet,et al.  Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[253]  N. Suzuki,et al.  Narrow Band Imaging for Detection of Dysplasia in Colitis: A Randomized Controlled Trial , 2012, The American Journal of Gastroenterology.

[254]  B. Nørgård,et al.  Pre‐operative use of anti‐TNF‐α agents and the risk of post‐operative complications in patients with ulcerative colitis – a nationwide cohort study , 2012, Alimentary pharmacology & therapeutics.

[255]  A. Kohn,et al.  Adenocarcinoma below stapled ileoanal anastomosis after restorative proctocolectomy for ulcerative colitis , 2012, Updates in Surgery.

[256]  E. Israeli,et al.  Effects of guided imagery with relaxation training on anxiety and quality of life among patients with inflammatory bowel disease , 2012, Psychology & health.

[257]  D. Drossman,et al.  Narcotic use for inflammatory bowel disease and risk factors during hospitalization , 2012, Inflammatory bowel diseases.

[258]  T. Matsui,et al.  Double‐blind, placebo‐controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid‐refractory ulcerative colitis , 2012, Inflammatory bowel diseases.

[259]  D. Hommes,et al.  Mesalazine in left-sided ulcerative colitis: efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing. , 2012, Journal of Crohn's & colitis.

[260]  E. Dekker,et al.  The prevalence of dysplasia in the ileoanal pouch following restorative proctocolectomy for ulcerative colitis with associated dysplasia , 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[261]  L. Wu,et al.  The diagnostic accuracy of chromoendoscopy for dysplasia in ulcerative colitis: meta‐analysis of six randomized controlled trials , 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[262]  M. Holick,et al.  Vitamin D supplementation: guidelines and evidence for subclinical deficiency , 2012, Current opinion in gastroenterology.

[263]  G. Rogler,et al.  Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis - an open pilot study. , 2012, Journal of Crohn's & colitis.

[264]  P. Moayyedi,et al.  Efficacy of Oral vs. Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Meta-Analysis , 2012, The American Journal of Gastroenterology.

[265]  E. Jung,et al.  Comparison between quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound and results of histopathological scoring in ulcerative colitis , 2012, International Journal of Colorectal Disease.

[266]  P. Munkholm,et al.  Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. , 2011, Journal of Crohn's & colitis.

[267]  L. Leifeld,et al.  Mesalazine granules are superior to Eudragit‐L‐coated mesalazine tablets for induction of remission in distal ulcerative colitis – a pooled analysis , 2011, Alimentary pharmacology & therapeutics.

[268]  L. Peyrin-Biroulet,et al.  Cytomegalovirus Load in Inflamed Intestinal Tissue Is Predictive of Resistance to Immunosuppressive Therapy in Ulcerative Colitis , 2011, The American Journal of Gastroenterology.

[269]  D. Altman,et al.  Translational Gastroenterology , 2011 .

[270]  W. Bemelman,et al.  Less adhesiolysis and hernia repair during completion proctocolectomy after laparoscopic emergency colectomy for ulcerative colitis , 2011, Surgical Endoscopy.

[271]  P. Rutgeerts,et al.  Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. , 2011, Gastroenterology.

[272]  J. Llach,et al.  Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study. , 2011, Gastrointestinal endoscopy.

[273]  P. Marteau,et al.  FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. , 2011, Gastroenterology.

[274]  T. Hlavatý,et al.  Colorectal cancer screening in patients with ulcerative and crohn's colitis with use of colonoscopy, chromoendoscopy and confocal endomicroscopy , 2011, European journal of gastroenterology & hepatology.

[275]  M. Manns,et al.  [Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline]. , 2011, Zeitschrift fur Gastroenterologie.

[276]  M. V. van Oijen,et al.  Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease , 2011, Gut.

[277]  S. Travis,et al.  Randomised clinical trial: early assessment after 2 weeks of high‐dose mesalazine for moderately active ulcerative colitis – new light on a familiar question , 2011, Alimentary pharmacology & therapeutics.

[278]  K. Rezvani,et al.  Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[279]  S. Saxena,et al.  Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease , 2011, Alimentary pharmacology & therapeutics.

[280]  C. Hawkey,et al.  Comparison of High Definition with Standard White Light Endoscopy for Detection of Dysplastic Lesions During Surveillance Colonoscopy in Patients with Colonic Inflammatory Bowel Disease , 2011, Inflammatory bowel diseases.

[281]  David C. Wilson,et al.  Consensus for Managing Acute Severe Ulcerative Colitis in Children: A Systematic Review and Joint Statement From ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN , 2011, The American Journal of Gastroenterology.

[282]  V. Fazio,et al.  Irritable pouch syndrome is characterized by visceral hypersensitivity , 2011, Inflammatory bowel diseases.

[283]  P. Moayyedi,et al.  Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis , 2011, The American Journal of Gastroenterology.

[284]  H. El‐Serag,et al.  Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature , 2011, The American Journal of Gastroenterology.

[285]  L Susan Wieland,et al.  Development and classification of an operational definition of complementary and alternative medicine for the Cochrane collaboration. , 2011, Alternative therapies in health and medicine.

[286]  A. Darzi,et al.  Volume analysis of outcome following restorative proctocolectomy , 2011, The British journal of surgery.

[287]  E. Horváth-Puhó,et al.  Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study , 2011, Gut.

[288]  J. Mössner,et al.  Vaccination coverage in immunosuppressed patients: results of a regional health services research study. , 2011, Deutsches Arzteblatt international.

[289]  Pamela Sears,et al.  Fidaxomicin versus vancomycin for Clostridium difficile infection. , 2011, The New England journal of medicine.

[290]  A. Vcev,et al.  Randomised clinical trial: a comparative dose‐finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis , 2011, Alimentary pharmacology & therapeutics.

[291]  W. Dixon,et al.  Extended Report , 2022 .

[292]  E. Dekker,et al.  Pilot study of probe-based confocal laser endomicroscopy during colonoscopic surveillance of patients with longstanding ulcerative colitis. , 2011, Endoscopy.

[293]  D. Present,et al.  Cyclosporine is Safe and Effective in Patients With Severe Ulcerative Colitis , 2011, Journal of clinical gastroenterology.

[294]  M. Verhoef,et al.  Use of complementary and alternative medicine by patients with inflammatory bowel disease , 2011, Inflammatory bowel diseases.

[295]  L. A. Christensen,et al.  Treatment of acute ulcerative colitis with infliximab, a retrospective study from three Danish hospitals. , 2011, Journal of Crohn's & colitis.

[296]  Frank Heller,et al.  Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols , 2011, International Journal of Colorectal Disease.

[297]  S. Schreiber,et al.  Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial , 2011, Gut.

[298]  A. Griffiths,et al.  Maintenance of remission in inflammatory bowel disease using omega‐3 fatty acids (fish oil): A systematic review and meta‐analyses , 2011, Inflammatory bowel diseases.

[299]  S. Targan,et al.  Randomised clinical trial: herbal extract HMPL‐004 in active ulcerative colitis – a double‐blind comparison with sustained release mesalazine , 2011, Alimentary pharmacology & therapeutics.

[300]  Bo Yang,et al.  A multi-center, randomized, single-blind, controlled clinical study on the efficacy of composite sophora colon-soluble capsules in treating ulcerative colitis , 2010, Chinese journal of integrative medicine.

[301]  Z. Cohen,et al.  Oncologic Outcome in Patients With Ulcerative Colitis Associated With Dyplasia or Cancer Who Underwent Stapled or Handsewn Ileal Pouch-Anal Anastomosis , 2010, Diseases of the colon and rectum.

[302]  M. Vieth,et al.  Clinical trial: A novel high‐dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500‐mg suppository thrice daily in active ulcerative proctitis , 2010, Inflammatory bowel diseases.

[303]  J. Kierkuś,et al.  Efficacy and safety of mesalamine suppositories for treatment of ulcerative proctitis in children and adolescents , 2010, Inflammatory bowel diseases.

[304]  A. Dignass,et al.  Diagnosis and management of iron deficiency anemia in patients with IBD , 2010, Nature Reviews Gastroenterology &Hepatology.

[305]  P. Hellström,et al.  Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3‐year follow‐up of the Swedish‐Danish controlled infliximab study , 2010, Alimentary pharmacology & therapeutics.

[306]  W. Reinisch,et al.  Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines. , 2010, Journal of Crohn's & colitis.

[307]  F. Clavel-Chapelon,et al.  Animal Protein Intake and Risk of Inflammatory Bowel Disease: The E3N Prospective Study , 2010, The American Journal of Gastroenterology.

[308]  A. Ananthakrishnan,et al.  Impact of Clostridium difficile on inflammatory bowel disease , 2010, Expert review of gastroenterology & hepatology.

[309]  J. Muir,et al.  Diarrhoea during enteral nutrition is predicted by the poorly absorbed short‐chain carbohydrate (FODMAP) content of the formula , 2010, Alimentary pharmacology & therapeutics.

[310]  L. Brandt,et al.  Glucocorticoids Are Associated With Increased Risk of Short-Term Mortality in Hospitalized Patients With Clostridium difficile-Associated Disease , 2010, The American Journal of Gastroenterology.

[311]  R. Fedorak,et al.  Treatment of ulcerative colitis with adalimumab or infliximab: long‐term follow‐up of a single‐centre cohort , 2010, Alimentary pharmacology & therapeutics.

[312]  S. Ng,et al.  Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis , 2010, Inflammatory bowel diseases.

[313]  M. Lamet.  A Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Mesalamine Suppositories 1 g at Bedtime and 500 mg Twice Daily in Patients with Active Mild-to-Moderate Ulcerative Proctitis , 2010, Digestive Diseases and Sciences.

[314]  P. V. van Rheenen,et al.  Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis , 2010, BMJ : British Medical Journal.

[315]  W. Sandborn,et al.  Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease , 2010, The American Journal of Gastroenterology.

[316]  S. Gallus,et al.  Are Colonoscopy and Bowel Ultrasound Useful for Assessing Response to Short-Term Therapy and Predicting Disease Outcome of Moderate-to-Severe Forms of Ulcerative Colitis?: A Prospective Study , 2010, The American Journal of Gastroenterology.

[317]  R. Steele,et al.  Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002) , 2010, Gut.

[318]  P. Rutgeerts,et al.  Infliximab, azathioprine, or combination therapy for Crohn's disease. , 2010, The New England journal of medicine.

[319]  C. Divino,et al.  Laparoscopic subtotal colectomy for medically refractory ulcerative colitis: the time has come , 2010, Surgical Endoscopy.

[320]  B. Warren,et al.  Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications , 2010, The British journal of surgery.

[321]  N. Packer,et al.  Does physical activity affect quality of life, disease symptoms and immune measures in patients with inflammatory bowel disease? A systematic review. , 2010, The Journal of sports medicine and physical fitness.

[322]  O. Inatomi,et al.  Factors affecting the efficacy of cyclosporin A therapy for refractory ulcerative colitis , 2010, Journal of gastroenterology and hepatology.

[323]  J. West,et al.  Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study , 2010, The Lancet.

[324]  Xiaojian Wu,et al.  The role of laparoscopic surgery for ulcerative colitis: systematic review with meta-analysis , 2010, International Journal of Colorectal Disease.

[325]  P. Gentile,et al.  Mesalazine vanishing time from rectal mucosa following its topical administration. , 2010, Journal of Crohn's & colitis.

[326]  R. Gearry,et al.  Population‐based cases control study of inflammatory bowel disease risk factors , 2010, Journal of gastroenterology and hepatology.

[327]  M. Thabane,et al.  Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis. , 2010, The Cochrane database of systematic reviews.

[328]  I. Lavery,et al.  Clinical outcomes of ileorectal anastomosis for ulcerative colitis , 2009, The British journal of surgery.

[329]  P. Renzulli,et al.  Ulcerative colitis: Correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C‐reactive protein, and blood leukocytes , 2009, Inflammatory bowel diseases.

[330]  F. Carrat,et al.  Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study , 2009, The Lancet.

[331]  A. Lyakhovich,et al.  Systematic review: molecular chemoprevention of colorectal malignancy by mesalazine , 2009, Alimentary pharmacology & therapeutics.

[332]  K. Jeejeebhoy.  Zinc: an essential trace element for parenteral nutrition. , 2009, Gastroenterology.

[333]  D. Hommes,et al.  Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease , 2009, British Journal of Cancer.

[334]  J. Satsangi,et al.  Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease. , 2009, The Journal of pediatrics.

[335]  S. McCartney,et al.  Efficacy of methotrexate in Crohn’s disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine , 2009, Alimentary pharmacology & therapeutics.

[336]  J. Maul,et al.  Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[337]  M. Silverberg,et al.  Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis , 2009, Gut.

[338]  V. Fazio,et al.  Outcomes for Patients Undergoing Continent Ileostomy After a Failed Ileal Pouch-Anal Anastomosis , 2009, Diseases of the colon and rectum.

[339]  A. Griffiths,et al.  Appraisal of the pediatric ulcerative colitis activity index (PUCAI) , 2009, Inflammatory bowel diseases.

[340]  S. Schneeweiss,et al.  Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections , 2009, Alimentary pharmacology & therapeutics.

[341]  G. Porro,et al.  Maintenance Treatment With Azathioprine in Ulcerative Colitis: Outcome and Predictive Factors After Drug Withdrawal , 2009, The American Journal of Gastroenterology.

[342]  T. Stijnen,et al.  Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[343]  P. Rutgeerts,et al.  Corticosteroids but not infliximab increase short‐term postoperative infectious complications in patients with ulcerative colitis , 2009, Inflammatory bowel diseases.

[344]  H. Tilg,et al.  Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. , 2009, Journal of Crohn's & colitis.

[345]  J. Askling,et al.  Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. , 2009, Gastroenterology.

[346]  D. Schwartz,et al.  Prevalence and Outcome of Anemia After Restorative Proctocolectomy: A Clinical Literature Review , 2009, Diseases of the colon and rectum.

[347]  A. Rink,et al.  Does Mesorectal Preservation Protect the Ileoanal Anastomosis after Restorative Proctocolectomy? , 2009, Journal of Gastrointestinal Surgery.

[348]  J. Goldblum,et al.  Administration of adalimumab in the treatment of Crohn’s disease of the ileal pouch , 2009, Alimentary pharmacology & therapeutics.

[349]  R. Jaussaud,et al.  Fatal Epstein-Barr Virus Primo Infection in a 25-Year-Old Man Treated with Azathioprine for Crohn's Disease , 2009, Journal of Clinical Microbiology.

[350]  E. Kuipers,et al.  Local application of tacrolimus in distal colitis: Feasible and safe , 2009, Inflammatory bowel diseases.

[351]  U. Sack,et al.  Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. , 2009, Rheumatology.

[352]  D. Larson,et al.  Minimally Invasive Subtotal Colectomy and Ileal Pouch-Anal Anastomosis for Fulminant Ulcerative Colitis: A Reasonable Approach? , 2009, Diseases of the colon and rectum.

[353]  J. Fleshman,et al.  Subtotal colectomy for toxic and fulminant colitis in the era of immunosuppressive therapy , 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[354]  W. Bemelman,et al.  Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis. , 2009, The Cochrane database of systematic reviews.

[355]  J. Fleshman,et al.  Laparoscopic vs. Open Total Abdominal Colectomy for Severe Colitis: Impact on Recovery and Subsequent Completion Restorative Proctectomy , 2009, Diseases of the colon and rectum.

[356]  Karen Davies,et al.  Fecal Calprotectin and Lactoferrin as Noninvasive Markers of Pediatric Inflammatory Bowel Disease , 2009, Journal of pediatric gastroenterology and nutrition.

[357]  O. Dewit,et al.  Mesalamine Foam Enema Versus Mesalamine Liquid Enema in Active Left-Sided Ulcerative Colitis , 2008, The American Journal of Gastroenterology.

[358]  J. Cinatl,et al.  The impact of treatment with tumour necrosis factor‐α antagonists on the course of chronic viral infections: a review of the literature , 2008, The British journal of dermatology.

[359]  N. Harpaz,et al.  Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[360]  R. Vega,et al.  Cytomegalovirus infection in ulcerative colitis: A prospective, comparative study on prevalence and diagnostic strategy , 2008, Inflammatory bowel diseases.

[361]  G. Porro,et al.  How long is it advisable to prolong maintenance treatment of patients with ulcerative colitis? , 2008, Inflammatory bowel diseases.

[362]  A. Opekun,et al.  Rising Incidence of Inflammatory Bowel Disease Among Children: A 12-year Study , 2010, Journal of pediatric gastroenterology and nutrition.

[363]  T. Chiba,et al.  Long‐term effect of tacrolimus therapy in patients with refractory ulcerative colitis , 2008, Alimentary pharmacology & therapeutics.

[364]  K. Van Steen,et al.  Long-term outcome after infliximab for refractory ulcerative colitis. , 2008, Journal of Crohn's & colitis.

[365]  A. Bousvaros,et al.  Nutritional concerns in pediatric inflammatory bowel disease patients. , 2008, Molecular nutrition & food research.

[366]  R. D'Incà,et al.  Can Calprotectin Predict Relapse Risk in Inflammatory Bowel Disease? , 2008, The American Journal of Gastroenterology.

[367]  G. Nguyen,et al.  Nationwide prevalence and prognostic significance of clinically diagnosable protein‐calorie malnutrition in hospitalized inflammatory bowel disease patients , 2008, Inflammatory bowel diseases.

[368]  B. Shen.  Impact of preoperative infliximab use on postoperative infectious complications in ulcerative colitis: the price we have to pay? , 2008, Inflammatory bowel diseases.

[369]  F. Remzi,et al.  Rifaximin for maintenance therapy in antibiotic-dependent pouchitis , 2008, BMC gastroenterology.

[370]  F. Remzi,et al.  Infliximab in Ulcerative Colitis is Associated with an Increased Risk of Postoperative Complications After Restorative Proctocolectomy , 2008, Diseases of the colon and rectum.

[371]  Janice Sorensen,et al.  EuroOOPS: an international, multicentre study to implement nutritional risk screening and evaluate clinical outcome. , 2008, Clinical nutrition.

[372]  G. Kaplan,et al.  A National Survey of the Prevalence and Impact of Clostridium difficile Infection Among Hospitalized Inflammatory Bowel Disease Patients , 2008, The American Journal of Gastroenterology.

[373]  D. Jewell,et al.  Indeterminate colitis: A review of the concept — What's in a name? , 2008, Inflammatory bowel diseases.

[374]  A. Griffiths,et al.  Guidelines for the management of growth failure in childhood inflammatory bowel disease. , 2008, Inflammatory bowel diseases.

[375]  A. Dixon,et al.  Laparoscopic emergency and elective surgery for ulcerative colitis , 2008, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[376]  H. Maarleveld,et al.  Infection control measures to limit the spread of Clostridium difficile. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[377]  S. Kugathasan,et al.  Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease , 2008, Inflammatory bowel diseases.

[378]  D. Hommes,et al.  More right‐sided IBD‐associated colorectal cancer in patients with primary sclerosing cholangitis , 2008, Inflammatory bowel diseases.

[379]  Roelof J Bennink,et al.  Magnetic resonance imaging in Crohn's disease , 2008 .

[380]  A. Zinsmeister,et al.  Risk factors for opportunistic infections in patients with inflammatory bowel disease. , 2008, Gastroenterology.

[381]  D. Hommes,et al.  High frequency of early colorectal cancer in inflammatory bowel disease , 2008, Gut.

[382]  G. Lau.  Hepatitis B reactivation after chemotherapy: two decades of clinical research , 2008, Hepatology international.

[383]  A. Forbes,et al.  European evidence-based Consensus on the management of ulcerative colitis: Special situations. , 2008, Journal of Crohn's & colitis.

[384]  S. Schreiber,et al.  Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis , 2008, Gut.

[385]  A. Buchman,et al.  Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohn's disease: A single‐center experience , 2008, Inflammatory bowel diseases.

[386]  E. Scherl,et al.  Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: Toward a standard of care , 2008, Inflammatory bowel diseases.

[387]  A. Griffiths,et al.  Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy , 2007, Gut.

[388]  Z. Cohen,et al.  Improved Outcome Due to Increased Experience and Individualized Management of Leaks After Ileal Pouch-Anal Anastomosis , 2007, Annals of surgery.

[389]  M. Goldacre,et al.  Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies , 2007, BMJ : British Medical Journal.

[390]  P. Brigidi,et al.  High-Dose Probiotics for the Treatment of Active Pouchitis , 2007, Diseases of the colon and rectum.

[391]  N. Harpaz,et al.  Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. , 2007, Gastroenterology.

[392]  A. Ananthakrishnan,et al.  Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease , 2007, Gut.

[393]  M. Vatn,et al.  Are There Any Differences in Phenotype or Disease Course Between Familial and Sporadic Cases of Inflammatory Bowel Disease? Results of a Population-Based Follow-Up Study , 2007, The American Journal of Gastroenterology.

[394]  S. Kuriyama,et al.  Effect of weekend 5‐aminosalicylic acid (mesalazine) enema as maintenance therapy for ulcerative colitis: Results from a randomized controlled study , 2007, Inflammatory bowel diseases.

[395]  M. Vatn,et al.  Ulcerative Colitis: Patient Characteristics May Predict 10-Yr Disease Recurrence in a European-Wide Population-Based Cohort , 2007, The American Journal of Gastroenterology.

[396]  A. Griffiths,et al.  Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. , 2007, Gastroenterology.

[397]  Antonius Schneider,et al.  Acupuncture treatment in gastrointestinal diseases: a systematic review. , 2007, World journal of gastroenterology.

[398]  F. Manguso,et al.  Meta‐analysis: the efficacy of rectal beclomethasone dipropionate vs. 5‐aminosalicylic acid in mild to moderate distal ulcerative colitis , 2007, Alimentary pharmacology & therapeutics.

[399]  Y. Maeura,et al.  Adenocarcinoma Arising Below an Ileoanal Anastomosis After Restorative Proctocolectomy for Ulcerative Colitis: Report of a Case , 2007, Surgery Today.

[400]  A. Nienhaus,et al.  Empfehlungen für die Umgebungsuntersuchungen bei Tuberkulose , 2007 .

[401]  A. Darzi,et al.  Meta‐analysis of short‐term and long‐term outcomes of J, W and S ileal reservoirs for restorative proctocolectomy , 2007, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[402]  R. Elashoff,et al.  Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[403]  J. Mchugh,et al.  The Diagnostic Value of Endoscopic Terminal Ileum Biopsies , 2007, The American Journal of Gastroenterology.

[404]  A. D. Rodgers,et al.  CRP Correlates with Clinical Score in Ulcerative Colitis but Not in Crohn’s Disease , 2007, Digestive Diseases and Sciences.

[405]  P. Rufo,et al.  Fecal Lactoferrin Is a Sensitive and Specific Marker of Disease Activity in Children and Young Adults With Inflammatory Bowel Disease , 2007, Journal of pediatric gastroenterology and nutrition.

[406]  D. Rubin,et al.  5‐Aminosalicylic Acid Therapy and the Risk of Colorectal Cancer Among Patients with Inflammatory Bowel Disease , 2007, Inflammatory bowel diseases.

[407]  A. Sapino,et al.  Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study , 2007, BMC gastroenterology.

[408]  R. Lovegrove,et al.  Comparison of short-term outcomes of laparoscopic vs open approaches to ileal pouch surgery , 2007, International Journal of Colorectal Disease.

[409]  T. Thomas,et al.  Meta‐analysis: cancer risk of low‐grade dysplasia in chronic ulcerative colitis , 2007, Alimentary pharmacology & therapeutics.

[410]  Kimberly A. Reske,et al.  Incidence of Clostridium difficile infection in inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[411]  R. Kiesslich,et al.  Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. , 2007, Gastroenterology.

[412]  D. Hommes,et al.  Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. , 2007, Endoscopy.

[413]  A. Befeler,et al.  High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis , 2007, Current gastroenterology reports.

[414]  H. Goto,et al.  Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan. , 2007, World journal of gastroenterology.

[415]  V. Fazio,et al.  Combined Ciprofloxacin and Tinidazole Therapy in the Treatment of Chronic Refractory Pouchitis , 2007, Diseases of the colon and rectum.

[416]  R. Lovegrove,et al.  The Effect of Crohn’s Disease on Outcomes After Restorative Proctocolectomy , 2007, Diseases of the colon and rectum.

[417]  H. Ogata,et al.  Cytomegalovirus Is Frequently Reactivated and Disappears Without Antiviral Agents in Ulcerative Colitis Patients , 2007, The American Journal of Gastroenterology.

[418]  A. Michalsen,et al.  Effects of a comprehensive lifestyle modification program on quality-of-life in patients with ulcerative colitis: A twelve-month follow-up , 2007, Scandinavian journal of gastroenterology.

[419]  C. O'Morain,et al.  The prevalence of genetic and serologic markers in an unselected European population‐based cohort of IBD patients , 2007, Inflammatory bowel diseases.

[420]  V. Fazio,et al.  Risk Factors for Anemia in Patients with Ileal Pouch-Anal Anastomosis , 2007, Diseases of the colon and rectum.

[421]  M. Sata,et al.  Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[422]  S. Galandiuk,et al.  Smoking and inflammatory bowel disease: a meta-analysis. , 2006, Mayo Clinic proceedings.

[423]  S. Schluender,et al.  Can a Meta-Analysis Answer the Question: Is Mucosectomy and Handsewn or Double-Stapled Anastomosis Better in Ileal Pouch-Anal Anastomosis? , 2006, The American surgeon.

[424]  H. Steinhart,et al.  Medical management of left‐sided ulcerative colitis and ulcerative proctitis: Critical evaluation of therapeutic trials , 2006, Inflammatory bowel diseases.

[425]  S. Vermeire.  Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease , 2006, Alimentary pharmacology & therapeutics.

[426]  L. Hultén,et al.  The place for colectomy and ileorectal anastomosis: a valid surgical option for ulcerative colitis? , 2006, Techniques in Coloproctology.

[427]  E. Schiff,et al.  Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[428]  G. Lichtenstein,et al.  Quality of life after proctocolectomy with ileoanal anastomosis for patients with ulcerative colitis. , 2006, Journal of clinical gastroenterology.

[429]  A. Konstantinidou,et al.  Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease , 2006, Inflammatory bowel diseases.

[430]  A. Zinsmeister,et al.  Incidence and Prognosis of Colorectal Dysplasia in Inflammatory Bowel Disease: A Population‐based Study from Olmsted County, Minnesota , 2006, Inflammatory bowel diseases.

[431]  D. Tompkins,et al.  Comparative Analysis of Prevalence, Risk Factors, and Molecular Epidemiology of Antibiotic-Associated Diarrhea Due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus , 2006, Journal of Clinical Microbiology.

[432]  A. Akobeng,et al.  Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis. , 2006, The Cochrane database of systematic reviews.

[433]  H. Drummond,et al.  The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5‐year UK inception cohort , 2006, Alimentary pharmacology & therapeutics.

[434]  A. Darzi,et al.  A Comparison of Hand-Sewn Versus Stapled Ileal Pouch Anal Anastomosis (IPAA) Following Proctocolectomy: A Meta-Analysis of 4183 Patients , 2006, Annals of surgery.

[435]  P. Rutgeerts,et al.  Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[436]  A. Zinsmeister,et al.  Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. , 2006, Gastroenterology.

[437]  A. Gasbarrini,et al.  Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis , 2006, Alimentary pharmacology & therapeutics.

[438]  O. Maeda,et al.  Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis , 2006, Gut.

[439]  B. Wiedenmann,et al.  Tacrolimus Is Safe and Effective in Patients with Severe Steroid-Refractory or Steroid-Dependent Inflammatory Bowel Disease—A Long-Term Follow-Up , 2006, The American Journal of Gastroenterology.

[440]  N. Suzuki,et al.  Judgement of the quality of bowel preparation at screening flexible sigmoidoscopy is associated with variability in adenoma detection rates. , 2006, Endoscopy.

[441]  D. Blondin,et al.  Multi-detector CT-colonography in inflammatory bowel disease: prospective analysis of CT-findings to high-resolution video colonoscopy. , 2006, European journal of radiology.

[442]  M. Braga,et al.  ESPEN Guidelines on Enteral Nutrition: Surgery including organ transplantation. , 2006, Clinical nutrition.

[443]  L. Melton,et al.  Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. , 2006, Gastroenterology.

[444]  A. Forbes,et al.  Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. , 2006, Gastroenterology.

[445]  C. Dejong,et al.  ESPEN Guidelines on Enteral Nutrition: Gastroenterology. , 2006, Clinical nutrition.

[446]  P. Lakatos,et al.  Risk factors for ulcerative colitis‐associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: Results of a population‐based study , 2006, Inflammatory bowel diseases.

[447]  T. Matsui,et al.  A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis , 2006, Gut.

[448]  Mahboob Rahman,et al.  Glucocorticoid use, other associated factors, and the risk of tuberculosis. , 2006, Arthritis and rheumatism.

[449]  J. Connor,et al.  Long-Term Outcome and Quality of Life After Continent Ileostomy , 2006, Diseases of the colon and rectum.

[450]  Simon Smale,et al.  Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[451]  J. Korzenik,et al.  Selective use of selective nonsteroidal anti-inflammatory drugs in inflammatory bowel disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[452]  W. Sandborn,et al.  Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[453]  A. M'Koma.  Serum biochemical evaluation of patients with functional pouches ten to 20 years after restorative proctocolectomy , 2006, International Journal of Colorectal Disease.

[454]  M. Vatn,et al.  Change of diagnosis during the first five years after onset of inflammatory bowel disease: Results of a prospective follow-up study (the IBSEN Study) , 2006, Scandinavian journal of gastroenterology.

[455]  C. Benoni,et al.  Does smoking influence the risk of pouchitis following ileal pouch anal anastomosis for ulcerative colitis? , 2006, Scandinavian journal of gastroenterology.

[456]  S. Willich,et al.  Acupuncture and moxibustion in the treatment of ulcerative colitis: A randomized controlled study , 2006, Scandinavian journal of gastroenterology.

[457]  Paul Rutgeerts,et al.  Infliximab for induction and maintenance therapy for ulcerative colitis. , 2005, The New England journal of medicine.

[458]  M. Pescovitz,et al.  Ganciclovir and Acyclovir Reduce the Risk of Post‐Transplant Lymphoproliferative Disorder in Renal Transplant Recipients , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[459]  S. Cross,et al.  Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. , 2005, Endoscopy.

[460]  T. Chattopadhyay,et al.  Outcome following emergency surgery for refractory severe ulcerative colitis in a tertiary care centre in India , 2005, BMC gastroenterology.

[461]  A. Day,et al.  Role of esophagogastroduodenoscopy in the initial assessment of children with inflammatory bowel disease , 2005, Journal of gastroenterology and hepatology.

[462]  N. Harpaz,et al.  Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[463]  M. Vieth,et al.  Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment , 2005, Gut.

[464]  J. Trickett,et al.  Management of the rectal stump after emergency sub‐total colectomy: which surgical option is associated with the lowest morbidity? , 2005, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[465]  I. Ekman,et al.  Thirty Years of Experience Living With a Continent Ileostomy , 2005, Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society.

[466]  S. Reif,et al.  Breastfeeding and risk of inflammatory bowel disease. , 2005, The American journal of clinical nutrition.

[467]  A. Michalsen,et al.  Effects of Mind-Body Therapy on Quality of Life and Neuroendocrine and Cellular Immune Functions in Patients with Ulcerative Colitis , 2005, Psychotherapy and Psychosomatics.

[468]  D. Thorley-Lawson.  EBV the prototypical human tumor virus--just how bad is it? , 2005, The Journal of allergy and clinical immunology.

[469]  D. Jewell,et al.  Cancer surveillance in ulcerative colitis , 2005, The British journal of surgery.

[470]  G. Porro,et al.  A rare cause of diuretic refractory ascites , 2005, Gut.

[471]  P. Marteau,et al.  An unusual cause of soft tissue infection , 2005, Gut.

[472]  G. Porro,et al.  Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[473]  J. Terdiman,et al.  Effect of 5-Aminosalicylate Use on Colorectal Cancer and Dysplasia Risk: A Systematic Review and Metaanalysis of Observational Studies , 2005, The American Journal of Gastroenterology.

[474]  Å. Danielsson,et al.  Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. , 2005, Gastroenterology.

[475]  M. Toruner,et al.  Endoscopic Factors in the Diagnosis of Colorectal Dysplasia in Chronic Inflammatory Bowel Disease , 2005, Inflammatory bowel diseases.

[476]  Joel V Weinstock,et al.  Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. , 2005, Gastroenterology.

[477]  A. Michalsen,et al.  Amount of Systemic Steroid Medication Is a Strong Predictor for the Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease.: Results From a German National Survey , 2005, Inflammatory bowel diseases.

[478]  S. Leveson,et al.  Rifaximin‐ciprofloxacin combination therapy is effective in chronic active refractory pouchitis , 2005, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[479]  M. Bottai,et al.  Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn’s disease , 2005, Gut.

[480]  Feza H. Remzi,et al.  Evaluation of the Learning Curve in Ileal Pouch–Anal Anastomosis Surgery , 2005, Annals of surgery.

[481]  K. Fellermann,et al.  Mesenteric Pulsatility Index Analysis Predicts Response to Azathioprine in Patients with Crohn's Disease , 2005, Inflammatory bowel diseases.

[482]  D. Sanders,et al.  The Incidence of Self-prescribed Oral Complementary and Alternative Medicine Use by Patients With Gastrointestinal Diseases , 2005, Journal of clinical gastroenterology.

[483]  K. Soares-Weiser,et al.  Cyclosporine A for induction of remission in severe ulcerative colitis. , 2005, The Cochrane database of systematic reviews.

[484]  J. Debatin,et al.  Magnetic resonance colonography for the detection of inflammatory diseases of the large bowel: quantifying the inflammatory activity , 2005, Gut.

[485]  M. Vatn,et al.  Outcome of four weeks’ intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis , 2005, Scandinavian journal of gastroenterology.

[486]  D. Gouma,et al.  Hand-Assisted Laparoscopic Versus Open Restorative Proctocolectomy With Ileal Pouch Anal Anastomosis: A Randomized Trial , 2004, Annals of surgery.

[487]  P. Munkholm,et al.  Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[488]  Pradip K. Singh,et al.  Is Routine Ileoscopy Useful? An Observational Study of Procedure Times, Diagnostic Yield, and Learning Curve , 2004, The American Journal of Gastroenterology.

[489]  A. Forbes,et al.  Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk , 2004, Gut.

[490]  D. Symmons,et al.  Systematic review: is ingestion of paracetamol or non‐steroidal anti‐inflammatory drugs associated with exacerbations of inflammatory bowel disease? , 2004, Alimentary pharmacology & therapeutics.

[491]  U. Ghoshal,et al.  Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. , 2004, Journal of medical microbiology.

[492]  R. Willén,et al.  The risk of dysplasia and cancer in the ileal pouch mucosa after restorative proctocolectomy for ulcerative proctocolitis is low: A long‐term term follow‐up study , 2004, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[493]  U. Böcker,et al.  Inflammatory Bowel Disease and Smoking: A Review of Epidemiology, Pathophysiology, and Therapeutic Implications , 2004, Inflammatory bowel diseases.

[494]  S. Reif,et al.  Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. , 2004, The American journal of clinical nutrition.

[495]  M. Stolte,et al.  Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine , 2004, Gut.

[496]  W. Fleig,et al.  [Ulcerative colitis. Nutrition]. , 2004, Zeitschrift fur Gastroenterologie.

[497]  Paul Rutgeerts,et al.  C-Reactive Protein as a Marker for Inflammatory Bowel Disease , 2004, Inflammatory bowel diseases.

[498]  A. Forbes,et al.  Most dysplasia in ulcerative colitis is visible at colonoscopy. , 2004, Gastrointestinal endoscopy.

[499]  F. González‐Huix,et al.  Chronic hepatitis B reactivation following infliximab therapy in Crohn’s disease patients: need for primary prophylaxis , 2004, Gut.

[500]  J. Achkar,et al.  Treatment of Rectal Cuff Inflammation (Cuffitis) in Patients with Ulcerative Colitis Following Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis , 2004, American Journal of Gastroenterology.

[501]  K. Van Steen,et al.  Interassay and interobserver variability in the detection of anti-neutrophil cytoplasmic antibodies in patients with ulcerative colitis. , 2004, Clinical chemistry.

[502]  D. Rampton,et al.  Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool , 2004, European journal of gastroenterology & hepatology.

[503]  V. Medici,et al.  Prognosis of severe attacks in ulcerative colitis: effect of intensive medical treatment. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[504]  B. Wiedenmann,et al.  Clinical Relevance of Transabdominal Ultrasonography and Magnetic Resonance Imaging in Patients With Inflammatory Bowel Disease of the Terminal Ileum and Large Bowel , 2004, Inflammatory bowel diseases.

[505]  R. Odze,et al.  Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[506]  S. Travis.  Predicting outcome in severe ulcerative colitis. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[507]  G. Radford-Smith,et al.  Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases , 2004, Gut.

[508]  D. Hommes,et al.  The Pathogenicity of Cytomegalovirus in Inflammatory Bowel Disease: A Systematic Review and Evidence-based Recommendations for Future Research , 2004, Inflammatory bowel diseases.

[509]  E. Loftus.  Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. , 2004, Gastroenterology.

[510]  C. Bernstein,et al.  Predictors of Alternative and Complementary Medicine Use in Inflammatory Bowel Disease: Do Measures of Conventional Health Care Utilization Relate to Use? , 2004, American Journal of Gastroenterology.

[511]  S. Plevy.  Do Serological Markers and Cytokines Determine the Indeterminate? , 2004, Journal of clinical gastroenterology.

[512]  R. Prescott,et al.  Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second‐line medical therapy or surgery , 2004, Alimentary pharmacology & therapeutics.

[513]  Noam Harpaz,et al.  Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. , 2004, Gastroenterology.

[514]  M. Schwab,et al.  Serum Procalcitonin Differentiates Inflammatory Bowel Disease and Self-limited Colitis , 2004, Inflammatory bowel diseases.

[515]  Y. Mahida,et al.  Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy , 2004, Gut.

[516]  O. Zmora,et al.  Outcome of Patients With Indeterminate Colitis Undergoing a Double-Stapled Ileal Pouch-Anal Anastomosis , 2004, Diseases of the colon and rectum.

[517]  T. Longacre,et al.  Cytomegalovirus Infection in Steroid-refractory Ulcerative Colitis: A Case-Control Study , 2004, The American journal of surgical pathology.

[518]  P. Miner,et al.  An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule‐1, in the treatment of chronic, unremitting pouchitis , 2004, Alimentary pharmacology & therapeutics.

[519]  M. Reyes-Múgica,et al.  Patterns of Inflammation in Mucosal Biopsies of Ulcerative Colitis: Perceived Differences in Pediatric Populations Are Limited to Children Younger Than 10 Years , 2004, The American journal of surgical pathology.

[520]  Alastair Forbes,et al.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. , 2004, Gastroenterology.

[521]  B. Korczowski,et al.  Serum procalcitonin and C‐reactive protein in children with diarrhoea of various aetiologies , 2004, Acta paediatrica.

[522]  A. Bousvaros,et al.  Pediatric Patients With Untreated Ulcerative Colitis May Present Initially With Unusual Morphologic Findings , 2004, The American journal of surgical pathology.

[523]  B. Cesana,et al.  Long‐term intermittent treatment with low‐dose 5‐aminosalicylic enemas is efficacious for remission maintenance in ulcerative colitis , 2004, Scandinavian journal of gastroenterology.

[524]  A. Røseth,et al.  Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease , 2004, Scandinavian journal of gastroenterology.

[525]  M. Kamm,et al.  Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis , 2003, Gut.

[526]  A. Gangl,et al.  Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis. , 2003, Endoscopy.

[527]  B. Sandhu,et al.  Presenting features of inflammatory bowel disease in Great Britain and Ireland , 2003, Archives of disease in childhood.

[528]  S. Gallus,et al.  Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel , 2003, Alimentary pharmacology & therapeutics.

[529]  Yunni-Yi Chen,et al.  Gross Versus Microscopic Pancolitis and the Occurrence of Neoplasia in Ulcerative Colitis , 2003, Inflammatory bowel diseases.

[530]  Noam Harpaz,et al.  Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. , 2003, Gastroenterology.

[531]  P. Beck,et al.  A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management , 2003, American Journal of Gastroenterology.

[532]  P. Rutgeerts,et al.  Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. , 2003, Gastroenterology.

[533]  M. Bellini,et al.  Role of faecal calprotectin as non-invasive marker of intestinal inflammation. , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[534]  E. Torres,et al.  Iron deficiency anemia as a presentation of pouchitis , 2003, American Journal of Gastroenterology.

[535]  D. Forman,et al.  Ten year follow up of ulcerative colitis patients with and without low grade dysplasia , 2003, Gut.

[536]  A. Sood,et al.  Azathioprine versus sulfasalazine in maintenance of remission in severe ulcerative colitis. , 2003, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[537]  Bernhard Nafe,et al.  Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. , 2003, Gastroenterology.

[538]  D. Jewell,et al.  Management of acute severe colitis. , 2003, Best practice & research. Clinical gastroenterology.

[539]  F. Carbonnel,et al.  Effects of appendicectomy on the course of ulcerative colitis , 2002, Gut.

[540]  F. Campbell,et al.  How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop , 2002, Journal of clinical pathology.

[541]  G. Radford-Smith,et al.  Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn’s disease , 2002, Gut.

[542]  E. Montgomery,et al.  Histopathology of Ulcerative Colitis in Initial Rectal Biopsy in Children , 2002, The American journal of surgical pathology.

[543]  C. Delaney,et al.  Equivalent Function, Quality of Life and Pouch Survival Rates After Ileal Pouch-Anal Anastomosis for Indeterminate and Ulcerative Colitis , 2002, Annals of surgery.

[544]  E. Kouroumalis,et al.  Role of Appendicitis and Appendectomy in the Pathogenesis of Ulcerative Colitis: A Critical Review , 2002, Inflammatory bowel diseases.

[545]  Lynne V McFarland,et al.  Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease , 2002, American Journal of Gastroenterology.

[546]  P. Heidenreich,et al.  Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. , 2002, Gastrointestinal endoscopy.

[547]  K. Geboes,et al.  Influence of treatment on morphological features of mucosal inflammation , 2002, Gut.

[548]  M. Kamm,et al.  Four‐week open‐label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis , 2002, Alimentary pharmacology & therapeutics.

[549]  C. Rubio,et al.  Low-Grade Dysplasia in Extensive, Long-Standing Inflammatory Bowel Disease , 2002, Diseases of the colon and rectum.

[550]  A. Stallmach,et al.  Role of Infections in the Manifestation or Reactivation of Inflammatory Bowel Diseases , 2002, Inflammatory bowel diseases.

[551]  D. Jewell,et al.  The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review , 2002, Gut.

[552]  A. Sood,et al.  The beneficial effect of azathioprine on maintenance of remission in severe ulcerative colitis , 2002, Journal of Gastroenterology.

[553]  J. Goldblum,et al.  Interobserver Variability in the Diagnosis of Ulcerative Colitis-Associated Dysplasia by Telepathology , 2002, Modern Pathology.

[554]  S. Dette,et al.  Ultrasonographic Findings Correspond to Clinical, Endoscopic, and Histologic Findings in Inflammatory Bowel Disease and Other Enterocolitides , 2002, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[555]  J. Achkar,et al.  Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis , 2002, American Journal of Gastroenterology.

[556]  C. Sirio,et al.  Fulminant Clostridium difficile: An Underappreciated and Increasing Cause of Death and Complications , 2002, Annals of surgery.

[557]  R. Löfberg,et al.  Effect of Budesonide Enema on Remission and Relapse Rate in Distal Ulcerative Colitis and Proctitis , 2002, Scandinavian journal of gastroenterology.

[558]  J. Bai,et al.  Budesonide enema in pouchitis—a double‐blind, double‐dummy, controlled trial , 2002, Alimentary pharmacology & therapeutics.

[559]  E. Ben-Arye,et al.  Wheat Grass Juice in the Treatment of Active Distal Ulcerative Colitis: A Randomized Double-blind Placebo-controlled Trial , 2002, Scandinavian journal of gastroenterology.

[560]  H. Nagura,et al.  Observer variation of diagnoses based on simple biopsy criteria differentiating among Crohn's disease, ulcerative colitis, and other forms of colitis , 2001, Journal of gastroenterology and hepatology.

[561]  J. Achkar,et al.  A Randomized Clinical Trial of Ciprofloxacin and Metronidazole to Treat Acute Pouchitis , 2001, Inflammatory bowel diseases.

[562]  H. Järvinen,et al.  Long term metabolic consequences of ileal pouch–anal anastomosis for ulcerative colitis , 2001, American Journal of Gastroenterology.

[563]  D. Jewell,et al.  Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications , 2001, Diseases of the colon and rectum.

[564]  A. Zinsmeister,et al.  The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. , 2001, Gastroenterology.

[565]  F. Carbonnel,et al.  Impact of cessation of smoking on the course of ulcerative colitis , 2001, American Journal of Gastroenterology.

[566]  R. Lüdtke,et al.  Effects of gum resin of Boswellia serrata in patients with chronic colitis. , 2001, Planta medica.

[567]  J. Olsen,et al.  Appendectomy and subsequent risk of inflammatory bowel diseases. , 2001, Surgery.

[568]  S. Targan,et al.  Outcome of cytomegalovirus infections in patients with inflammatory bowel disease , 2001, American Journal of Gastroenterology.

[569]  K Abrams,et al.  Inter‐observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis , 2001, The Journal of pathology.

[570]  L. Mortelmans,et al.  Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. , 2001, Gastroenterology.

[571]  M. Rowe,et al.  Epstein–Barr Virus and Cancer , 2001 .

[572]  W. Kremers,et al.  Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. , 2001, Gastroenterology.

[573]  K. Abrams,et al.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.

[574]  F. Autschbach,et al.  Long-term Follow-Up After Ileoanal Pouch Procedure: Algorithm for Diagnosis, Classification, and Management of Pouchitis , 2001 .

[575]  F. Autschbach,et al.  Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. , 2001, Gastroenterology.

[576]  G. Pietrosi,et al.  Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis , 2001, American Journal of Gastroenterology.

[577]  Howard K Song,et al.  Nutritional support for Crohn's disease. , 2001, The Surgical clinics of North America.

[578]  M. Kimmey,et al.  Ursodiol Use Is Associated with Lower Prevalence of Colonic Neoplasia in Patients with Ulcerative Colitis and Primary Sclerosing Cholangitis , 2001, Annals of Internal Medicine.

[579]  B. Persson,et al.  Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine , 2001, Diseases of the colon and rectum.

[580]  J. Tiainen,et al.  Histological and macroscopic changes in the pelvic pouch: long‐term follow up after restorative proctocolectomy for ulcerative colitis (UC) , 2001, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[581]  R. Moreno-otero,et al.  6‐Mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid‐dependent inflammatory bowel disease , 2000, European journal of gastroenterology & hepatology.

[582]  S. Castle,et al.  Clinical relevance of age-related immune dysfunction. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[583]  P. Brigidi,et al.  Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. , 2000, Gastroenterology.

[584]  Carbonnel,et al.  Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis , 2000, Alimentary pharmacology & therapeutics.

[585]  A. Munakata,et al.  Simple mucosal biopsy criteria differentiating among Crohn disease, ulcerative colitis, and other forms of colitis: measurement of validity. , 2000, Scandinavian journal of gastroenterology.

[586]  K. Abrams,et al.  Colorectal cancer prevention in ulcerative colitis: a case‐control study , 2000, Alimentary pharmacology & therapeutics.

[587]  Hebden,et al.  Limited exposure of the healthy distal colon to orally‐dosed formulation is further exaggerated in active left‐sided ulcerative colitis , 2000, Alimentary Pharmacology and Therapeutics.

[588]  J. Matikainen,et al.  Long-term Clinical Outcome and Anemia after Restorative Proctocolectomy for Ulcerative Colitis , 2000, Scandinavian journal of gastroenterology.

[589]  N. Harpaz,et al.  Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. , 1999, Gastroenterology.

[590]  K. Fellermann,et al.  Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: a prospective follow up study , 1999, Gut.

[591]  A. Herbay.  Histopathologische Diagnostik chronisch- entzündlicher Darmerkrankungen Historischer Rückblick und aktuelle Übersicht , 1999, Der Pathologe.

[592]  Z. Cohen,et al.  Functional outcome of conversion of ileorectal anastomosis to ileal pouch-anal anastomosis in patients with familial adenomatous polyposis and ulcerative colitis , 1999, Diseases of the colon and rectum.

[593]  P. Brigidi,et al.  Antibiotic combination therapy in patients with chronic, treatment‐resistant pouchitis , 1999, Alimentary pharmacology & therapeutics.

[594]  S. Hanauer,et al.  Intravenous cyclosporin in ulcerative colitis: a five-year experience , 1999, American Journal of Gastroenterology.

[595]  G. D'Haens,et al.  Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial. , 1999, Gastroenterology.

[596]  M. Verhoef,et al.  Complementary and alternative medicine use by patients with inflammatory bowel disease: An Internet survey. , 1999, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[597]  K. Sharp,et al.  Ileoanal Pouch Procedures: Clinical Outcomes and Quality-of-Life Assessment , 1999, The American surgeon.

[598]  R. Hurst,et al.  The Implications of Acute Pouchitis on the Long‐Term Functional Results after Restorative Proctocolectomy , 1998, Inflammatory bowel diseases.

[599]  S. Hollerbach,et al.  The accuracy of abdominal ultrasound in the assessment of bowel disorders. , 1998, Scandinavian journal of gastroenterology.

[600]  R. Löfberg,et al.  Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis , 1998, European journal of gastroenterology & hepatology.

[601]  C. Kleer,et al.  Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time. , 1998, The American journal of surgical pathology.

[602]  G. Kauffmann,et al.  MRI of pouch-related fistulas in ulcerative colitis after restorative proctocolectomy. , 1998, Journal of computer assisted tomography.

[603]  M. Levine,et al.  Total proctocolectomy and ileoanal pouch: the role of contrast studies for evaluating postoperative leaks , 1998, Abdominal Imaging.

[604]  R. Farouk,et al.  J ileal pouch–anal anastomosis for chronic ulcerative colitis: complications and long‐term outcome in 1310 patients , 1998, The British journal of surgery.

[605]  A. Ekbom,et al.  Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study , 1998, Gut.

[606]  S S Cross,et al.  Audit of the histopathological diagnosis of non-neoplastic colorectal biopsies: achievable standards for the diagnosis of inflammatory bowel disease. , 1998, Journal of clinical pathology.

[607]  D. Jewell,et al.  Pharmacotherapy for inducing and maintaining remission in pouchitis. , 1998, The Cochrane database of systematic reviews.

[608]  R. Nicholls,et al.  Pouchitis: Risk Factors, Etiology, and Treatment , 1998, World Journal of Surgery.

[609]  H. Jick,et al.  Appendectomy protects against ulcerative colitis. , 1998, Epidemiology.

[610]  P. Rutgeerts,et al.  Is Ileoscopy With Biopsy Worthwhile in Patients Presenting With Symptoms of Inflammatory Bowel Disease? , 1998, American Journal of Gastroenterology.

[611]  P. Gionchetti,et al.  Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis , 1998, Diseases of the colon and rectum.

[612]  J. Mayberry,et al.  Oral or rectal administration of drugs in IBD? , 1997, Alimentary pharmacology & therapeutics.

[613]  G. Porro,et al.  Azathioprine in steroid-resistant and steroid-dependent ulcerative colitis. , 1997, Journal of clinical gastroenterology.

[614]  A. Amorosi,et al.  Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study. , 1997, The American journal of gastroenterology.

[615]  A. Olson,et al.  Colonoscopy or sigmoidoscopy as the initial evaluation of pediatric patients with colitis: a survey of physician behavior and a cost analysis. , 1997, Journal of pediatric gastroenterology and nutrition.

[616]  P. Skipworth,et al.  Reliability of rectal biopsy in distinguishing between chronic inflammatory bowel disease and acute self‐limiting colitis , 1997, Histopathology.

[617]  J. Marshall,et al.  Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. , 1997, Gut.

[618]  K. Batts,et al.  Transdermal Nicotine for Mildly to Moderately Active Ulcerative Colitis , 1997, Annals of Internal Medicine.

[619]  J. Bruel,et al.  Sonographic assessment of the normal and abnormal bowel wall in nondiverticular ileitis and colitis , 1997, Abdominal Imaging.

[620]  S Gallivan,et al.  Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. , 1997, Journal of clinical pathology.

[621]  É. Lerebours,et al.  Intravenous cyclosporine in attacks of ulcerative colitis , 1996, Digestive Diseases and Sciences.

[622]  H. Goldman.  Significance and detection of dysplasia in chronic colitis , 1996, Cancer.

[623]  E. Cabré,et al.  Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis. , 1996, The American journal of gastroenterology.

[624]  German and Austrian ImipenemCilastatin Study Group,et al.  Treatment of distal ulcerative colitis with short-chain fatty acid enemas a placebo-controlled trial , 1996, Digestive Diseases and Sciences.

[625]  P. Gionchetti,et al.  Management of severe ulcerative colitis with the help of high resolution ultrasonography. , 1996, The American journal of gastroenterology.

[626]  J. Baker,et al.  Treatment of left‐sided ulcerative colitis with butyrate enemas: a controlled trial , 1996, Alimentary pharmacology & therapeutics.

[627]  R. Löfberg,et al.  Pouchitis following pelvic pouch operation for ulcerative colitis , 1996, Diseases of the colon and rectum.

[628]  C. Bodian,et al.  The long-term outcome of ulcerative colitis treated with 6-mercaptopurine. , 1996, The American journal of gastroenterology.

[629]  R. Newcombe,et al.  Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis. , 1996, European journal of gastroenterology & hepatology.

[630]  P. Fockens,et al.  Beclomethasone dipropionate (3 mg) versus 5-aminosalicylic acid (2 g) versus the combination of both (3 mg/2 g) as retention enemas in active ulcerative proctitis. , 1996, European journal of gastroenterology & hepatology.

[631]  M. Molinari,et al.  Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. , 1996, Archives of surgery.

[632]  A. Lavy,et al.  Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial. , 1996, Gastroenterology.

[633]  N. Mortensen,et al.  Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. , 1996, Gut.

[634]  N. LaRusso,et al.  Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. , 1996, Gut.

[635]  J. Ioannidis,et al.  A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens. , 1996, Archives of internal medicine.

[636]  J. Church,et al.  IIeal Pouch‐Anal Anastomoses Complications and Function in 1005 Patients , 1995, Annals of surgery.

[637]  L. Karch,et al.  Subtotal colectomy with Hartmann's pouch for inflammatory bowel disease , 1995, Diseases of the colon and rectum.

[638]  S Meyers,et al.  Treatment of Clostridium difficile infection. , 1995, The Mount Sinai journal of medicine, New York.

[639]  R. Newcombe,et al.  Transdermal nicotine as maintenance therapy for ulcerative colitis. , 1995, The New England journal of medicine.

[640]  J. Church,et al.  Safety of urgent restorative proctocolectomy with ileal pouch-anal anastomosis for fulminant colitis , 1995, Diseases of the colon and rectum.

[641]  R. Westendorp,et al.  Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine. , 1995, Gut.

[642]  Z. Cohen,et al.  Assessment of peripouch inflammation after ileoanal anastomosis using endoluminal ultrasonography , 1995, Diseases of the colon and rectum.

[643]  A. Marino,et al.  Follow-up results of hematology data before and after restorative proctocolectomy , 1994, Diseases of the colon and rectum.

[644]  A Price,et al.  Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. , 1994, Gut.

[645]  P. Munkholm,et al.  Course of ulcerative colitis: analysis of changes in disease activity over years. , 1994, Gastroenterology.

[646]  S. Hanauer,et al.  Cyclosporine in severe ulcerative colitis refractory to steroid therapy. , 1994, The New England journal of medicine.

[647]  K. Batts,et al.  A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis. , 1994, Gastroenterology.

[648]  P. Rutgeerts,et al.  Restorative proctocolectomy in elective and emergency cases of ulcerative colitis , 1994, International Journal of Colorectal Disease.

[649]  A. Bjørneklett,et al.  Topical metronidazole treatment in pouchitis. , 1994, Scandinavian journal of gastroenterology.

[650]  K. Batts,et al.  Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. , 1994, Mayo Clinic proceedings.

[651]  R. Stenling,et al.  Colorectal cancer surveillance in patients with ulcerative colitis , 1994, The British journal of surgery.

[652]  B. Sandstedt,et al.  A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Histologic course during the 1st year after presentation. , 1994, Scandinavian journal of gastroenterology.

[653]  R G Newcombe,et al.  Transdermal nicotine for active ulcerative colitis. , 1994, The New England journal of medicine.

[654]  G. Lux,et al.  Ultrasonography as a primary diagnostic tool in patients with inflammatory disease and tumors of the small intestine and large bowel , 1994, Journal of clinical ultrasound : JCU.

[655]  C. Bernstein,et al.  Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? , 1994, The Lancet.

[656]  J. Markowitz,et al.  Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis. , 1993, The American journal of gastroenterology.

[657]  R. Odze,et al.  Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis. , 1993, The American journal of surgical pathology.

[658]  R. Haggitt,et al.  Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. , 1993, Gastroenterology.

[659]  L. Hultén,et al.  Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch. , 1993, Scandinavian journal of gastroenterology.

[660]  C. Ainley,et al.  A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis , 1993, Alimentary pharmacology & therapeutics.

[661]  W. Roediger,et al.  Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. , 1993, Gastroenterology.

[662]  E. Cabré,et al.  Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis. , 1993, The American journal of gastroenterology.

[663]  A. Zinsmeister,et al.  Dysplasia in chronic ulcerative colitis: Implications for colonoscopic surveillance , 1992, Diseases of the colon and rectum.

[664]  A. Axon,et al.  Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. , 1992, BMJ.

[665]  D. Sachar,et al.  Benign and malignant colorectal strictures in ulcerative colitis. , 1992, Gut.

[666]  M. Scheurlen,et al.  Microbic Superinfection in Relapse of Inflammatory Bowel Disease , 1992, Journal of clinical gastroenterology.

[667]  C. Meijer,et al.  Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications. , 1991, Gut.

[668]  D. Jewell,et al.  Small bowel gas in severe ulcerative colitis. , 1991, Gut.

[669]  P. Sipponen,et al.  Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme. , 1991, Gut.

[670]  J. Murray,et al.  Pouchitis—Is it a wastebasket diagnosis? , 1991, Diseases of the colon and rectum.

[671]  L. Braslow.  Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. , 1991, Annals of surgery.

[672]  S. Riley,et al.  Microscopic activity in ulcerative colitis: what does it mean? , 1991, Gut.

[673]  G. Järnerot,et al.  Colonoscopy during an attack of severe ulcerative colitis is a safe procedure and of great value in clinical decision making. , 1991, The American journal of gastroenterology.

[674]  H. Adami,et al.  Ulcerative colitis and colorectal cancer. A population-based study. , 1990, The New England journal of medicine.

[675]  A. Öst,et al.  Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study. , 1990, Gastroenterology.

[676]  L. Hultén,et al.  A prospective randomized comparison of two different pelvic pouch designs. , 1990, Scandinavian journal of gastroenterology.

[677]  J. Lennard-jones,et al.  Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. , 1990, Gut.

[678]  A. Axon,et al.  The role of azathioprine in the management of ulcerative colitis , 1990, Diseases of the colon and rectum.

[679]  D. Bostwick,et al.  Dysplasia and cancer complicating strictures in ulcerative colitis , 1990, Digestive Diseases and Sciences.

[680]  A. Stuck,et al.  Risk of infectious complications in patients taking glucocorticosteroids. , 1989, Reviews of infectious diseases.

[681]  J. Jass,et al.  Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. , 1989, Human pathology.

[682]  M. Therkildsen,et al.  The final outcome of patients presenting with their first episode of acute diarrhoea and an inflamed rectal mucosa with preserved crypt architecture. A clinicopathologic study. , 1989, Scandinavian journal of gastroenterology.

[683]  D. Jewell,et al.  High‐Dose Methylprednisolone in the Treatment of Active Ulcerative Colitis , 1988, Journal of clinical gastroenterology.

[684]  M. Davoli,et al.  Clinical and laboratory indicators of extent of ulcerative colitis. Serum C-reactive protein helps the most. , 1988, Journal of clinical gastroenterology.

[685]  W. Tremaine,et al.  Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. , 1987, The New England journal of medicine.

[686]  R. Pounder,et al.  The value of rectal biopsy in distinguishing self-limited colitis from early inflammatory bowel disease. , 1987, The Quarterly journal of medicine.

[687]  D. Häussinger,et al.  Bioavailability of zinc from zinc-histidine complexes. I. Comparison with zinc sulfate in healthy men. , 1987, The American journal of clinical nutrition.

[688]  L. Shaw,et al.  Relaxation training as a treatment for chronic pain caused by ulcerative colitis , 1987, Pain.

[689]  N. Heyder,et al.  Ultrasound findings in Crohn's disease and ulcerative colitis: A prospective study , 1987, Journal of clinical ultrasound : JCU.

[690]  E. Feuer,et al.  Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. , 1987, Journal of clinical gastroenterology.

[691]  H. Appelman,et al.  Histopathology differentiates acute self-limited colitis from ulcerative colitis. , 1987, Gastroenterology.

[692]  J. Heppell,et al.  Toxic megacolon , 1986, Diseases of the colon and rectum.

[693]  J. Lennard-jones,et al.  Controlled trial of bowel rest in the treatment of severe acute colitis. , 1986, Gut.

[694]  C. Smith,et al.  Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. , 1986, Gut.

[695]  M. Sivak,et al.  Surveillance for colonic carcinoma in ulcerative colitis. , 1985, Gastroenterology.

[696]  K. Lindor,et al.  Preoperative nutritional status and other factors that influence surgical outcome in patients with Crohn's disease. , 1985, Mayo Clinic proceedings.

[697]  R. Allan,et al.  Impact of preoperative weight loss and body composition changes on postoperative outcome in surgery for inflammatory bowel disease. , 1984, Gut.

[698]  D. Ransohoff,et al.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.

[699]  R. Pounder,et al.  Clostridium difficile and inflammatory bowel disease. , 1983, Gut.

[700]  C. Surawicz.  Serial sectioning of a portion of a rectal biopsy detects more focal abnormalities , 1982, Digestive Diseases and Sciences.

[701]  S. Wolman,et al.  Zinc in total parenteral nutrition: requirements and metabolic effects. , 1979, Gastroenterology.

[702]  A. Price.  Overlap in the spectrum of non-specific inflammatory bowel disease--'colitis indeterminate'. , 1978, Journal of clinical pathology.

[703]  C. Spicer,et al.  Assessment of severity in colitis: a preliminary study. , 1975, Gut.

[704]  D. Jewell,et al.  Azathioprine in Ulcerative Colitis: Final Report on Controlled Therapeutic Trial , 1974, British medical journal.

[705]  D. Jewell,et al.  Intensive intravenous regimen for severe attacks of ulcerative colitis. , 1974, Lancet.

[706]  S. Truelove,et al.  The course and prognosis of ulcerative colitis , 1963, Gut.

[707]  J. H. Baron,et al.  Out-patient Treatment of Ulcerative Colitis , 1962, British medical journal.

[708]  F. Jones,et al.  An Assessment of Prednisone, Salazopyrin, and Topical Hydrocortisone Hemisuccinate Used as Out-patient Treatment for Ulcerative Colitis , 1960, Gut.

[709]  S. Truelove,et al.  Cortisone and Corticotrophin in Ulcerative Colitis , 1959, British medical journal.

[710]  W. Silen,et al.  Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. , 1958, Surgery.

[711]  S. Truelove.  Cortisone in ulcerative colitis; preliminary report on a therapeutic trial. , 1954, Gastroenterologia.

[712]  Prateek Sharma,et al.  Surotomycin (a novel cyclic lipopeptide) vs Vancomycin for treatment of Clostridioides difficile infection: A systematic review and Meta-analysis. , 2019, Current clinical pharmacology.

[713]  K. Carroll,et al.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[714]  L. Lix,et al.  Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease , 2017 .

[715]  J. Lewis,et al.  Diet as a Trigger or Therapy for Inflammatory Bowel Diseases. , 2017, Gastroenterology.

[716]  Matthew Sims,et al.  Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. , 2017 .

[717]  W. Sandborn,et al.  Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis. , 2017, The New England journal of medicine.

[718]  U. Hofmann,et al.  Patient Education in a 14-month Randomised Trial Fails to Improve Adherence in Ulcerative Colitis: Influence of Demographic and Clinical Parameters on Non-adherence , 2017, Journal of Crohn's & colitis.

[719]  S. Ramamoorthy,et al.  Risk Factors , and Outcomes of Colorectal Cancer in Patients with Ulcerative Colitis with Low-Grade Dysplasia : A Systematic Review and Meta-analysis , 2016 .

[720]  W. Sandborn,et al.  C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis , 2015, The American Journal of Gastroenterology.

[721]  J. Langhorst,et al.  Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases. , 2015, Journal of Crohn's & colitis.

[722]  L. Stassen,et al.  European evidence based consensus on surgery for ulcerative colitis. , 2015, Journal of Crohn's & colitis.

[723]  P. Malfertheiner,et al.  [S2k-guideline gastrointestinal infectious diseases and Whipple's disease]. , 2015, Zeitschrift fur Gastroenterologie.

[724]  L. Peyrin-Biroulet,et al.  Association between pharmacokinetics of adalimumab and mucosal healing in patients with inflammatory bowel diseases. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[725]  M. Skup,et al.  Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis. , 2014, Gastroenterology.

[726]  P. Rutgeerts,et al.  Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis. , 2014, Gastroenterology.

[727]  P. Rutgeerts,et al.  Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis. , 2014, Gastroenterology.

[728]  J. Langhorst,et al.  [Updated German clinical practice guideline on "Diagnosis and treatment of Crohn's disease" 2014]. , 2014, Zeitschrift fur Gastroenterologie.

[729]  C. Kelly,et al.  Clostridium difficile infection in the inflammatory bowel disease patient. , 2013, Inflammatory bowel diseases.

[730]  A. Caliendo,et al.  Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. , 2013, Transplantation.

[731]  B. Warner,et al.  Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. , 2012, Gastroenterology.

[732]  B. Feagan,et al.  Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. , 2012, The Cochrane database of systematic reviews.

[733]  L. von Müller,et al.  [Current data and trends on the development of antibiotic resistance of Clostridium difficile]. , 2012, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.

[734]  M. Eveslage,et al.  Treatment benefi t or survival of the fi ttest : what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient ? , 2011 .

[735]  R. Lovegrove,et al.  To divert or not to divert: A retrospective analysis of variables that influence ileostomy omission in ileal pouch surgery. , 2011, Archives of surgery.

[736]  M. Picco.  Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease , 2011 .

[737]  A. Griffiths,et al.  Oral budesonide for induction of remission in ulcerative colitis. , 2010, The Cochrane database of systematic reviews.

[738]  M. Picco.  Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis , 2010 .

[739]  J. Stockman.  Differentiating Ulcerative Colitis from Crohn Disease in Children and Young Adults: Report of a Working Group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America , 2009 .

[740]  H. Tilg,et al.  European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. , 2009, Journal of Crohn's & colitis.

[741]  A. Griffiths,et al.  Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. , 2009, The Cochrane database of systematic reviews.

[742]  J. Efron,et al.  Laparoscopic ileal pouch–anal anastomosis reduces abdominal and pelvic adhesions , 2008, Surgical Endoscopy.

[743]  I. Zabalza Estévez,et al.  [Oral budesonide in the treatment of chronic refractory pouchitis]. , 2008, Gastroenterologia y hepatologia.

[744]  A. Bousvaros,et al.  Pouch outcomes among children with ulcerative colitis treated with calcineurin inhibitors before ileal pouch anal anastomosis surgery. , 2007, Journal of pediatric surgery.

[745]  A. Griffiths,et al.  Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[746]  A. Timmer,et al.  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. , 2007, The Cochrane database of systematic reviews.

[747]  O. Bouché,et al.  Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal survey. , 2006, Gastroenterologie clinique et biologique.

[748]  R. Farrell,et al.  Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[749]  J. Hugot,et al.  Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria. , 2005, Journal of pediatric gastroenterology and nutrition.

[750]  J. Lennard-jones,et al.  Macroscopic lesions in dysplasia and carcinoma complicating ulcerative colitis , 2005, Digestive Diseases and Sciences.

[751]  M. V. M. Frcs,et al.  Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis , 2005, Digestive Diseases and Sciences.

[752]  T. Berg,et al.  [Procedures for problematic situations with hepatitis B]. , 2004, Zeitschrift fur Gastroenterologie.

[753]  M. Vatn,et al.  Assessment of mucosal inflammation and circulation in response to probiotics in patients operated with ileal pouch anal anastomosis for ulcerative colitis. , 2003, Scandinavian journal of gastroenterology.

[754]  A. Poullis,et al.  Review article: faecal markers in the assessment of activity in inflammatory bowel disease. , 2002, Alimentary pharmacology & therapeutics.

[755]  F. Reinholt,et al.  Cancer risk assessment in long-standing pouchitis. DNA aberrations are rare in transformed neoplastic pelvic pouch mucosa. , 2002, International journal of colorectal disease.

[756]  A. Cohen,et al.  Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. , 2001, Gastroenterology.

[757]  W. Kruis,et al.  Chronic inflammatory bowel disease and cancer. , 2000, Hepato-gastroenterology.

[758]  A. Garrido Serrano,et al.  [Fatal infectious mononucleosis during azathioprine treatment in Crohn's disease]. , 2000, Gastroenterologia y hepatologia.

[759]  R. Riddell,et al.  Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis. , 1999, Scandinavian journal of gastroenterology.

[760]  G. Porro,et al.  Ultrasonography in the evaluation of extension, activity, and follow-up of ulcerative colitis. , 1999, Scandinavian journal of gastroenterology.

[761]  M. Gassull,et al.  Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). , 1999, The American journal of gastroenterology.

[762]  D. Jewell,et al.  Medical therapy for induction and maintenance of remission in pouchitis: a systematic review. , 1999, Inflammatory bowel diseases.

[763]  C. Herfarth,et al.  [Long-term quality of life after continence-preserving proctocolectomy for ulcerative colitis and familial adenomatous polyposis]. , 1998, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[764]  M. Hassan,et al.  Ultrasonographic assessment of inflammatory bowel disease in children: comparison with ileocolonoscopy. , 1997, The Journal of pediatrics.

[765]  R. Lüdtke,et al.  Effects of Boswellia serrata gum resin in patients with ulcerative colitis. , 1997, European journal of medical research.

[766]  D. Seidner,et al.  The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. , 1997, Gastroenterology.

[767]  G. Mantzaris,et al.  Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis. , 1994, The American journal of gastroenterology.

[768]  N. Harpaz,et al.  Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy. , 1994, The American journal of gastroenterology.

[769]  D. Jewell,et al.  Cyclosporin A retention enemas in refractory distal ulcerative colitis and 'pouchitis'. , 1993, Scandinavian journal of gastroenterology.

[770]  A. Gent,et al.  Search for enteric microbial pathogens in patients with ulcerative colitis. , 1992, Digestion.

[771]  J. Nel.  [Management of patients with AMS 800 urinary artificial sphincter]. , 1991, Nursing RSA = Verpleging RSA.

[772]  B. Engelstad,et al.  Ileoanal pouches: comparison of CT, scintigraphy, and contrast enemas for diagnosing postsurgical complications. , 1990, AJR. American journal of roentgenology.

[773]  R. Haggitt.  Differential diagnosis of colitis. , 1990, Monographs in pathology.

[774]  B. Korelitz,et al.  The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis. , 1990, The American journal of gastroenterology.

[775]  J. Silva,et al.  Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. , 1989, The American journal of medicine.

[776]  C. Surawicz,et al.  Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease. , 1984, Gastroenterology.

[777]  J. Rombeau,et al.  Preoperative total parenteral nutrition and surgical outcome in patients with inflammatory bowel disease. , 1982, American journal of surgery.

[778]  B. Levin,et al.  Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. , 1981, Gastroenterology.

[779]  C. Surawicz,et al.  Rectal biopsy in the diagnosis of Crohn's disease: value of multiple biopsies and serial sectioning. , 1981, Gastroenterology.

[780]  G PLACITELLI,et al.  [Ulcerative colitis]. , 1958, La Riforma medica.

[781]  S. Truelove,et al.  Cortisone in ulcerative colitis; final report on a therapeutic trial. , 1955, British medical journal.

[782]  B. Koletzko,et al.  Klinische Ernährung in der Gastroenterologie (Teil 4) – Chronisch-entzündliche Darmerkrankungen , 2022 .